Advertisement

Proktologie pp 113-230 | Cite as

Perianal lokalisierte Krankheitsbilder

  • Ernst Stein

Zusammenfassung

Die Kenntnis der bevorzugt oder nur gelegentlich im Anal- und/oder Perianalbereich lokalisierten dermatologischen Krankheitsbilder ist Voraussetzung einer differenzierten und damit letztlich befriedigenden proktologischen Arbeit.

Literatur

  1. 1.
    Alexander-Williams J (1983) Pruritus ani. extracta dermatologica 5: 433–439Google Scholar
  2. 2.
    Bernhard JD (1994) Itch: Diagnosis and treatment. McGraw-Hill, New YorkGoogle Scholar
  3. 3.
    Brasch J (1993) Lokalisierter Pruritus. Z Hautkrankht 5: 332–334Google Scholar
  4. 4.
    Daniel GL, Longo WE, Vernava AM 3rd (1994) Pruritus ani. Causes and concerns. Dis Colon Rectum 37/7: 670–674CrossRefGoogle Scholar
  5. 5.
    Dasan S, Neill SM, Donaldson DR, Scott HJ (1999) Treatment of persistent pruritus ani in a combined colorectal and dermatologic clinic. Br J Surg 86/10: 1337–1340CrossRefGoogle Scholar
  6. 6.
    Denman ST (1986) A review of pruritus. J Am Acad Dermatol 14: 375–392PubMedCrossRefGoogle Scholar
  7. 7.
    Giordano M, Rebesco B, Torelli I, Blanco G, Cattarini G (1999) Pruritus ani. Minerva Chir 54/12: 885–891Google Scholar
  8. 8.
    Greither A (1980) Pruritus und Prurigo. Hautarzt 31: 397–405PubMedGoogle Scholar
  9. 9.
    Handwerker HO (1993) Neurophysiologische Mechanismen des Juckens. Z Hautkrankht 11: 730–735Google Scholar
  10. 10.
    Jones DJ (1992) ABC of colorectal diseases. Pruritus ani. BMJ 305/6853: 575–577CrossRefGoogle Scholar
  11. 11.
    Laurent A, Boucharlat J, Bosson JL, Derry A, Imbert R (1997) Psychological assessment of patients with idiopathic pruritus ani. Psychother Psychosom 66/3: 163–166CrossRefGoogle Scholar
  12. 12.
    Lyell A (1972) The itching patient. Scot Med J 17: 334PubMedGoogle Scholar
  13. 13.
    Marghescu S (1993) Pruritus sine materia. Z Hautkrankht 5: 335–337Google Scholar
  14. 14.
    Mauß J (1985) Pruritus ani. Dtsch Arztebl 54: 2726–2730Google Scholar
  15. 15.
    Pfenninger JL, Zainea GG (2001) Common anorectal conditions: Part 1. Symptoms and complaints. Am Fam Physician 63/12: 2391–2398Google Scholar
  16. 16.
    Steen KH et al. (1995) Die neuronale Vermittlung des Pruritus. Z Hautkrankht 1: 43–47Google Scholar
  17. 17.
    Steigleder GK (1986) Zur Differenzialdiagnose des Pruritus. Z Hautkrankht 12: 839Google Scholar
  18. 1.
    Amiry SA, Pride HB, Tyler WB (2001) Perianal pseudoverrucose papules and nodules mimicking condylomata acuminata and child sexual abuse. Cutis 67/4: 335–338Google Scholar
  19. 2.
    Altmeyer P (1973) Die Bedeutung tluorierter Glukokortikoide in der Aetiopathogenesis des Granuloma glutaeale infantum. Z Hautkrankht 48: 621–626Google Scholar
  20. 3.
    Bruckner-Tuderman L (1984) Granuloma glutaeale infantum. Hautarzt 37: 347–349Google Scholar
  21. 4.
    Drake LA, Dinehart SM, Farmer ER et al. (1996) Guidelines of care for the use of topical glucocorticosteroids. J Am Acad Dermatol 35/4: 615–619Google Scholar
  22. 5.
    Gysler A, Schafer-Korting M (2001) Glukokortikoide. In: Korting HC, Sterry W (Hrsg) Therapeutische Verfahren in der Dermatologie: Dermatika und Kosmetika. Blackwell, Berlin, S 10 1–111Google Scholar
  23. 6.
    Jacobs JA, Kolbach DN, Vermeulen AH, Smeets MH, Neumann HA (2001) Tinea incognito due to Trichophytom rubrum after local steroid therapy. Clin Infect Dis 33/12: E142–144CrossRefGoogle Scholar
  24. 7.
    Maekawa Y, Sakazaki Y, Hayashibara T (1978) Diaper area granuloma of the aged. Arch Dermatol 114/3: 382–383CrossRefGoogle Scholar
  25. 8.
    Raimer SS (2001) The safe use of topical corticosteroids in children. Pedriatr Ann 30/4: 225–229Google Scholar
  26. 9.
    Rodriguez Cano L, Gracia-Patos Briones V, Pedragosa Jove R, Castells Rodellas A (1994) Perianal pseudoverrucous papules and nodules after surgery of Hirschsprung disease. J Pedriatr 126/6: 914–916CrossRefGoogle Scholar
  27. 10.
    Solomon BA, Glass AT, Rabbin PE (1996) Tinea incognito and „over-the-counter“ potent topical steroids. Cutis 58/4: 295–296Google Scholar
  28. 11.
    Stein E (1974) Uncharakteristische dermatologische Krankheitsbilder durch Korikosteroid-KombinationsExterna. Anti Praxis 14: 613Google Scholar
  29. 12.
    Stein E (1976) Ursachen perianaler Hautaffektionen. Anti Praxis 90: 3526Google Scholar
  30. 13.
    Tappeiner J, Ptleger L (1971) Granuloma glutaeale infantum. Hautarzt 22: 383–388PubMedGoogle Scholar
  31. 14.
    Zeeuw R de, Praag MC van, Oranje AP (2000) Granuloma gluteale infantum: a case report. Pedriatr Dermatol 17/2: 141–143CrossRefGoogle Scholar
  32. 1.
    Andersen KE, Hjorth N, Menne T (1984) The baboon syndrome-systematically induced allergic contact dermatitis. Contact Dermatitis 10: 97–100PubMedCrossRefGoogle Scholar
  33. 2.
    Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2000) Leitlinie zum Krankheitsbild des Analekzems. Leitlinien der Deutschen Dermatologischen Gesellschaft. AMWF online, awmf@uni-duesseldorf.deGoogle Scholar
  34. 3.
    Bauer A, Geier J, Elsner P (2000) Allergic contact dermatitis in patients with anogenital complaints. J Reprod Med 45/8: 649–654Google Scholar
  35. 4.
    Blecher P, Korting HC (1992) Gesteigertes Risiko fUr Analekzeme durch Recycling-Hygienepapier? Dermatologie 6:5Google Scholar
  36. 5.
    Blecher P, Korting HC (1995) Tolerance to different toilet paper preparations: toxicological and allergological aspects. Dermatology 191/4: 299–304CrossRefGoogle Scholar
  37. 6.
    Groot AC de, Baar TJ, Terpstra H, Weyland JW (1991) Contact allergy to moist toilet paper. Contact Dermatitis 24/2: 135–136CrossRefGoogle Scholar
  38. 7.
    Herfs H, Schirren CG, Przybilla B, Plewig G (1993) Das „Baboon-Syndrom“. Hautarzt 44: 466–469PubMedGoogle Scholar
  39. 8.
    Hornstein OP (1984) Ekzemkrankheiten. Therapiewoche 34: 400–409Google Scholar
  40. 9.
    Hornstein OP (1986) Anmerkungen und Vorschlage zur Definition und Klassifikation der Ekzemkrankheiten. Z Hautkrankht 61: 18, 1281–1296Google Scholar
  41. 10.
    Kearney CR, Fewings J (2001) Allergic contact dermatitis to cinchocaine. Australas J Dermatol 4212: 118–119CrossRefGoogle Scholar
  42. 11.
    Lazarov A (1999) Perianal contact dermatitis caused by nail lacquer allergy. Am J Contact Dermat 10/1: 43–44CrossRefGoogle Scholar
  43. 12.
    Lechner T, Grytzmann B, Baurle G (1987) Hamatogenes allergisches Kontaktekzem nach oraler Gabe von Nystatin. Mykosen 30: 143–146PubMedCrossRefGoogle Scholar
  44. 13.
    Montag G, Weber L, Gall H (1996) Baboon-Syndrom auf Allopurinol. Aktuel Dermatol22: 311–313Google Scholar
  45. 14.
    Oostendorp I, Rakoski J (1991) Kontaktekzeme in der Analregion. Der Dtsch Dermatologe 39: 1317–1318Google Scholar
  46. 15.
    Peters K-P, Lechner T, Grytzmann B (1987) Perianal auftretende Arzneimittelreaktionen. In: Forstmann P, SchUler H, Alpers R (Hrsg) Aktuelle Koloproktologie, Bd 4. Edition Nymphenburg, MiinchenGoogle Scholar
  47. 16.
    Rietschel RL, Fowler JF (eds) (2001) Fisher's contact dermatitis, 5th edn. Lippincott Williams & Wilkins, PhiladelphiaGoogle Scholar
  48. 17.
    Ring J (1996) Zum Wandel des Ekzem-Begriffes: Klassisches versus atopisches Ekzem. Hautkrankht 10: 752–756Google Scholar
  49. 18.
    Rycroft RJG, Menne T, Frosch PJ (eds) (2001) Textbook of contact dermatitis, 3rd edn. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  50. 19.
    Stein E (1973) Kritische Betrachtung zur Anwendung von Cortikosteroid-Kombinations-Externa (CKE) bei Hautkrankheiten. Z Allgemeinmed 26: 1227–1233Google Scholar
  51. 20.
    Stein E (1994) Perianalekzem. Chir Gastroenterol 10: 299–302CrossRefGoogle Scholar
  52. 21.
    Waldmann T, Ponnighaus JM, Kowalzick L (1999) Baboon-Syndrom durch Amoxicillin. Akt Dermatol 25: 73–75Google Scholar
  53. 22.
    Weiss JM, Mockenhaupt M, Schöpf E, Simon JC (2001) Fixes Arzneimittelexanthem auf Terbinafin mit charakteristischem Verteilungsmuster eines Baboon-Syndroms. Hautarzt 52: 1104–1106PubMedCrossRefGoogle Scholar
  54. 1.
    Bolognia JL, Pawelek JM (1988) Biology of hypopigmentation. J Am Acad Dermatol1912:217–255Google Scholar
  55. 2.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  56. 3.
    Geel N van, Ongenae K, Naeyaert JM (2001) Surgical techniques for vitiligo. Dermatology 202/2: 162–166CrossRefGoogle Scholar
  57. 4.
    Iliev D, Elsner P (1998) An unusual hypopigmentation in occupational dermatology: presentation of a case and review of the literature. Dermatology 196/2: 248–250CrossRefGoogle Scholar
  58. 5.
    Le Poole C, Boissy RE (1997) Vitiligo. Semin Cutan Med Surg 16/1: 3–14CrossRefGoogle Scholar
  59. 6.
    Lerner EA, Sober AJ (1988) Chemical and pharmacologic agents that cause hyperpigmentation or hypopygmentation of the skin. Dermatol Clin 6/2: 327–337Google Scholar
  60. 7.
    Malakar S, Panda S (2001) Post-inflammatory depigmentation following allergic contact dermatitis to chloroxylenol. Br J Dermatol144/6: 1275–1276CrossRefGoogle Scholar
  61. 8.
    Nordlund JJ, Abdel-Malek ZA (1988) Mechanisms for post-inflammatory hyperpigmentation and hypopigmentation. Prog Clin Biol Res 256: 219–236PubMedGoogle Scholar
  62. 9.
    Pandya AG, Guevara IL (2000) Disorders of pigmentation. Dermatol Clin 1811: 91–98Google Scholar
  63. 10.
    Shaffrali F, Gawkrodger D (2000) Management of vitiligo. Clin Exp Dermatol 25/8: 575–579CrossRefGoogle Scholar
  64. 11.
    Westerhof W (2000) Vitiligo management update. Skin Therapy Lett 5/6: 1–2,5Google Scholar
  65. 1.
    Alexander SJ (1979) Squamous cell carcinoma in chronic hydradenitis suppurativa. A case report. Cancer 43: 745–748PubMedCrossRefGoogle Scholar
  66. 2.
    Attanoos RL, Appleton MA, Douglas-Jones AG (1995) The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands. Br J Dermatol 133/2: 254–258CrossRefGoogle Scholar
  67. 3.
    Bellomo R (1990) Chirurgische Behandlung des Morbus Verneuil. Coloproctology 1: 50–53Google Scholar
  68. 4.
    Black SB, Woods JW (1982) Squamous cell carcinoma complicating hydradenitis suppurativa. J Surg Oncol 19: 25–26PubMedCrossRefGoogle Scholar
  69. 5.
    Bierl H (1995) Differenzierte Akne-Therapie mit hoher Erfolgsquote. TW Dermatol 25: 239–242Google Scholar
  70. 6.
    Boer J, Weltevreden EF (1996) Hidradenitis suppurativa or acne inversa. A clinicopathologic study of early lesions. Br J Dermatol135/5: 721–725CrossRefGoogle Scholar
  71. 7.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  72. 8.
    Breuninger H, Wienert H (2001) Acne inversa. Dtsch Arztbl 98/44: C2293Google Scholar
  73. 9.
    DiGiovanna JJ (2001) Systemic retinoid therapy. Dermatol Clin 19/1: 161–167Google Scholar
  74. 10.
    Fanta D, Messeritsch-Fanta C (1999) Akne 1999: brauchen wir den Hautarzt noch? Hautarzt 50: 900–911PubMedCrossRefGoogle Scholar
  75. 11.
    Hartschuh W (1997) Acne inversa (Pyodermia fistulans sinifica). Coloproctology Verbandsnachrichten 19/1: 9–13Google Scholar
  76. 12.
    Jansen T, Romiti R, Plewig G (2000) Acne fulminans. Schwere Akne mit ungewohnlichem klinischem Verlauf. Dtsch Arzteb197/22: A1533–A1537Google Scholar
  77. 13.
    Jemec GB, Faber M, Gutschik E, Wendelboe P (1996) The bacteriology of hidradenitis suppurativa. Dermatology 193/3: 203–206CrossRefGoogle Scholar
  78. 14.
    Jemec GB, Heidenheim M, Nielsen NH (1996) The prevalence of hidradenitis suppurativa and its potential precursor lesions. JAm Acad Dermatol 35/2: 191–194CrossRefGoogle Scholar
  79. 15.
    Jemec GB, Thomsen BM, Hansen U (1997) The homogeneity of hidradenitis suppurativa lesions. A histological study of intra-individual variation. APMIS 105/5: 378–383CrossRefGoogle Scholar
  80. 16.
    Kaufer C, Axnick E (1988) Operative Therapie der Aknetetrade. Z Hautkrankht 63/7: 597–609Google Scholar
  81. 17.
    Kreißler-Haag D et al. (1994) Die mehrzeitige chirurgische Samerung der schweren perianalen und perigenitalen Pyodermien. Coloproctology 6: 371–374Google Scholar
  82. 18.
    Küster W, Rodder-Wehrmann O, Plewig G (1991) Acne inversa. Pathogenese und Genetik.Hautarzt 4211: 2–4Google Scholar
  83. 19.
    Kurzen H, Schönfelder-Funcke S, Hartschuh W (2000) Surgical treatment of acne inversa at the University of Heidelberg. Coloproctology 22: 76–80CrossRefGoogle Scholar
  84. 20.
    Lentner A (1995) Pyoderma fistulans sinifica (Acne inversa). H + G 70: 460Google Scholar
  85. 21.
    Lentner A, Rübben A, Wiener V (1992) Klinisches Erscheinungsbild und Therapie der Pyodermia fistulans sinifica (Acne inversa). Z Hautkrankht 67: 988–992Google Scholar
  86. 22.
    Michalowski R (1973) Akne conglobata mit spinozellularem Karzimnom. Hautarzt 24: 404PubMedGoogle Scholar
  87. 23.
    National Dermatology Working Group (1997) Isotretino in (roaccutane) usage-a South African consensus guideline. S Afr Med J 87110: 1410–1413Google Scholar
  88. 24.
    Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  89. 25.
    Plewig G (1983) Die sogenannten rezidivierenden SchweiBdrUsenabszesse und ihre chirurgische Behandlung. In: Schweiberer L (Hrsg) Chirurgische und plastisch-chirurgische Aspekte bei Infektionen und infizierten Defekten der Korperoberflache, der Extremitaten und der Analregion. Zuckschwert, MUnchen Bern WienGoogle Scholar
  90. 26.
    Plewig G, Steger M (1989) Acne inversa. In: Marks R, Plewig G (eds) Acne and related disorders. Martin Dunitz, LondonGoogle Scholar
  91. 28.
    Quintal D, Jackson R (1986) Aggressive squamous cell carcinoma arising in familial acne conglobata. J Am Acad Dermatol 14:207–214PubMedCrossRefGoogle Scholar
  92. 29.
    Rodder-Wehrmann O, Kuster W, Plewig G (1991) Acne inversa. Diagnose und Therapie. Hautarzt 4211: 5–8Google Scholar
  93. 30.
    Rompel R, Petres J (1995) Operative Akne-Therapie. H+G 70: 700–704Google Scholar
  94. 31.
    Verneuil A (1864) De l'hidrosadénite phlegmoneuse et des abces sudoripares. Arch Gen Med 114: 537–557Google Scholar
  95. 32.
    Verneuil A (1865) De l'hidrosadenite phlegmoneuse et des abces sudoripares. Arch Gen Med 115: 327–337Google Scholar
  96. 33.
    Verneuil A (1865) De hidrosadenite phlegmoneuse et des abces sudoripares. Arch Gen Med 115: 437–453Google Scholar
  97. 34.
    Wienert V, Breuninger H, Müller RPA (2001) Acne inversa. In: Korting HC, Callies R, Reusch M, Schlaeger M, Schöpf E, Sterry W (Hrsg) Dermatologische Qualitatssicherung-Leitlinien und Empfehlungen, 2. Aufl. Zuckschwerdt, MUnchen, S 32–39Google Scholar
  98. 1.
    Abboud B, Ingea H (1999) Recurrent squamous-cell carcinoma arising in sacrococcygeal pilonidal sinus tract: report of a case and reviwe of the literature. Dis Colon Rectum 42/4: 525–528CrossRefGoogle Scholar
  99. 2.
    AI-Hassan HK, Francis IM, Neglen P (1990) Primary closure or secundary granulation after excision of pilonidal sinus? Acta Chir Scand 156/10: 695–699Google Scholar
  100. 3.
    Anderson AW (1847) Hair extracted from an ulcer. Boston Med Surg 36: 74–76Google Scholar
  101. 4.
    Benhamou G, Vilotte J (1988) Kystes et sinus pilonidaux. Ann Dermatol Venerol 115: 95–97Google Scholar
  102. 5.
    Bock J-U et al. (1995) Therapie des Sinus pilonidalis. T W Dermatologie 25: 210–215Google Scholar
  103. 6.
    Buchmann P (1994) Lehrbuch der Proktologie, 3.Aufl. Huber, BernGoogle Scholar
  104. 7.
    Dahl HD, Henrich MH (1992) Licht-und elektronenmikroskopische Untersuchungen zur Pathogenese des Sinus pilonidalis und der Analfistel. Langenbecks Arch Chir 377: 118–124PubMedCrossRefGoogle Scholar
  105. 8.
    Davis KA, Mock CN, Versaci A, Lentrichia P (1994) Malignant degeneration of pilonidal cysts. Am Surg 60/3: 200–204Google Scholar
  106. 9.
    Denkers D, Girona J (1996) Der abszedierte Sinus pilonidalis der SteiBbeinregion-Moglichkeiten der chirurgischen Versorgung. Coloproctology 6:257–259Google Scholar
  107. 10.
    Fuzun M et al. (1994) Which technique for treatment of pilonidal sinus-open or closed? Dis Colon Rectum 37: 1148–1150PubMedCrossRefGoogle Scholar
  108. 11.
    Giebel D, Menningen R, Petrovici V (1994) Transpositionslappen bei der Behandlung des Sinus pilonidalis. Coloproctology 4: 255–262Google Scholar
  109. 12.
    Hodges RM (1889) Pilonidal sinus. Boston Med Surg J 103:485CrossRefGoogle Scholar
  110. 13.
    Hodgkin W (1998) Pilonidal sinus disease. J Wound Care. 7/9: 481–483Google Scholar
  111. 14.
    Khaira HS, Brown JH (1995) Excision and primary suture of pilonidal sinus. Ann R ColI Surg 77: 242–244Google Scholar
  112. 15.
    Kooistra HP (1942) Pilonidal sinuses: review of the literature and report of three hundred and fifty cases. Am J Surg 55: 3CrossRefGoogle Scholar
  113. 16.
    Kulayat MN, Gong M, Doerr RJ (1996) Multimodality treatment of squamous cell carcinoma complicating pilonidal disease. Am Surg 62/11: 922–929Google Scholar
  114. 17.
    Marks J et al. (1985) Pilonidal sinus excision-healing by open granulation. Br J Surg 72: 637–640PubMedCrossRefGoogle Scholar
  115. 18.
    Philipshen SJ, Gray G, Goldsmith E, Dineen P (1981) Carcinoma arising in pilonidal sinuses. Ann Surg 193/4: 506–512Google Scholar
  116. 19.
    Schneider IH, Thaler K, Kockerling F (1994) Treatment of pilonidal sinuses by phenol injections. Int J Colorectal Dis 9/4: 200–202CrossRefGoogle Scholar
  117. 20.
    Silva JH da (2000) Pilonidal cyst: cause and treatment. Dis Colon Rectum 43/8: 1146–1156CrossRefGoogle Scholar
  118. 21.
    Spivak H, Brooks VL, Nussbaum M, Friedman I (1996) Treatment of chronic pilonidal disease. Dis Colon Rectum 39/10: 1136–1139CrossRefGoogle Scholar
  119. 22.
    Sondenaa K et al. (1992) Morbidity and short term results in a randomised trial of open compared with closed treatment of chronic pilonidal sinus. Eur J Surg 158: 351–355PubMedGoogle Scholar
  120. 23.
    Sondenaa K et al. (1995) Bacteriology and complications of chronic pilonidal sinus treated with excision and primary suture. Int J Colorect Dis 10: 161–166CrossRefGoogle Scholar
  121. 24.
    Wienert V, Mlitz H, Prinz B (2001) Pilonidalsinus. In: Korting HC, Callies R, Reusch M, Schlaeger M, Schöpf E, Sterry W (Hrsg) Dermatologische Qualitatssicherung-Leitlinien und Empfehlungen, 2. Aufl., Zuckschwerdt, Miinchen, S 40–45Google Scholar
  122. 1.
    Abeck D, Mempel M, Seidl HP, Schnopp C, Ring J, Heeg K (2000) Impetigo contagiosa-Erregerspektrum und therapeutische Konsequenzen. Dtsch Med Wschr 125: 1257–1259PubMedCrossRefGoogle Scholar
  123. 2.
    Abeck D, Strom K, Schnopp C, Korting HC, Heeg K (2001) Pyodermien-Ein interdisziplinares Problem. Dtsch Arztebl 98/45: C2338ff.Google Scholar
  124. 3.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  125. 4.
    Darmstadt GL, Lane AT (1994) Impetigo: an overview. Pediatr Dermatol 11: 294–303Google Scholar
  126. 5.
    Korting HC, Neubert U, Abeck D (1998) Current antimicrobial susceptibility of cutaneous bacteria to first line antibiotics. Int J Antimicrob Agents 10:165–168PubMedCrossRefGoogle Scholar
  127. 6.
    Ochsendorf FR, Richter T, Niemczyk UM, Schafer V, Brade V, Milbradt R (2000) Prospektive Erfassung wichtiger bakterieller Erreger von Pyodermien und deren Invitro-Antibiotikaempfindlichkeit. Hautarzt 51:319–326PubMedCrossRefGoogle Scholar
  128. 1.
    Amren DP, Anderson AS, Wannamaker LW (1966) Perianal cellulitis associated with group A streptococci. Am J Dis Child 112/6: 546–552Google Scholar
  129. 2.
    Heidelberger A, Cremer H, Ring J, Abeck D (2000) Perianale streptogene Dermatitis. Hautarzt 5112: 86–89Google Scholar
  130. 3.
    Kokx NP, Comstock JA, Facklam RR (1987) Streptococcal perianal disease in children. Pediatrics 80/5: 659–663Google Scholar
  131. 4.
    Krol AL (1990) Perianal streptococcal dermatitis. Pediatr Dermatol 7/2: 97–100CrossRefGoogle Scholar
  132. 5.
    Mogielnicki NP, Schwartzmann JD, Elliott JA (2001) Perineal group A streptococcal disease in a pediatric practice. Pediatrics 10612: 276–281Google Scholar
  133. 6.
    Montemarano AD, James WD (1993) Staphylococcus aureus as a cause of perianal dermatitis. Pediatr Dermatol 10/3: 259–262CrossRefGoogle Scholar
  134. 7.
    Neri I, Bardazzi F, Marzaduri S, Patrizi A (1996) Perianal streptococcal dermatitis in adults. Br J Dermatol 135/5: 796–798CrossRefGoogle Scholar
  135. 8.
    Patrizi A, Costa AM, Fiorillo L, Neri I (1994) Perianal streptococcal dermatitis associated with guttate psoriasis and/or balanoposthitis: a study of five cases. Pediatr Dermatol11/2: 168–171CrossRefGoogle Scholar
  136. 9.
    Souillet AL, Truchot F, Jullien D, Dumas V, Faure M, Floret D, Claudy A (2000) Anite perianale streptococcique. Arch Pediatr 7/11: 1194–1196CrossRefGoogle Scholar
  137. 1.
    Allen S, Christmas TI, McKinney W, Parr D, Oliver GF (1990) The Auckland skin clinic tinea pedis and erythrasma study. N Z Med 103/896: 391–393Google Scholar
  138. 2.
    Golledge CL Phillips G (1991) Corynebacterium minutissimum infection. J Infect 2311:73–76CrossRefGoogle Scholar
  139. 3.
    Mattox TF, Rutgers J, Yoshimori RN, Bhatia NN (1993) Nonfluorescent erythrasma of the vulva. Obstet Gynecol 8115:862–864Google Scholar
  140. 4.
    Wharton JR, Wilson PL, Kincannon JM (1998) Erythrasma treated with single-dose clarithromycin. Arch Dermatol134/6: 671–672CrossRefGoogle Scholar
  141. 1.
    Bonifaz A, Saul A (2000) Comparative study between terbinafine 1 % emulsion-gel versus ketoconazole 2 % cream in tinea cruris and tinae corporis. Eur J Dermatol1O/2: 107–109Google Scholar
  142. 2.
    Gupta AK, Einarson TR, Summerbell RC, Shear NH (1998) An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs 55/5: 645–674CrossRefGoogle Scholar
  143. 3.
    Hay RJ (1999) New developments in antifungals. Int J Dermatol 38 (Supp12): 65–69PubMedGoogle Scholar
  144. 4.
    Heerden JS van, Vismer HF (1997) Tinea corporis/cruris: new treatment options. Dermatology 194 (Suppll): 14–18PubMedCrossRefGoogle Scholar
  145. 5.
    Hoog GS de, Guarro J (Hrsg.) (1995) Atlas of clinical fungi. Centraalbureau voor Schimmelcultures Baarn/ Delft, NLGoogle Scholar
  146. 6.
    Korting HC, Abeck D, Bernhardt HI et al. (2001) Tinea der freien Haut. In: Korting HC, Callies R, Reusch M, Schlaeger M, Schöpf E, Sterry W (Hrsg) Dermatologische Qualitatssicherung-Leitlinien und Empfehlungen, 2. Aufl. Zuckschwerdt, Miinchen, S 55–58Google Scholar
  147. 7.
    Keyser P de, Backer M de, Massart DL, Westelinck KJ (1994) Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study. Br J Dermatol 130 (Supp143): 22–25PubMedCrossRefGoogle Scholar
  148. 8.
    Silva-Tavares H, Alchorne MM, Fischman O (2001) Tinea cruris epidemiology (Sao Paulo, Brazil). Mycopathologia 149/3: 147–149CrossRefGoogle Scholar
  149. 9.
    Stein E (1995) Diseases of the anus and perianal region. In: Demis DJ (ed) Clinical dermatology, 22. Revision, Vol 4. Lippincott-Raven, Philadelphia New York, pp 1–21Google Scholar
  150. 10.
    Stein E (1996) Anale Hauterkrankungen: Dermatophytosen. Coloproctology 3: XIII–XVIGoogle Scholar
  151. 1.
    Baker DA (1994) Long-term suppressive therapy with acyclovir for recurrent genital herpes. J lnt Med Res 22 (Suppll). 24A–31AGoogle Scholar
  152. 2.
    Bratzke B, Orfanos CE, Stavermann T, Ehlers G (1991) Chronisch-erosiver, therapierefraktarer perianaler Herpes (TypII) mit Herpes-Proktitis bei AIDS. Hautarzt 42/2: 96–100Google Scholar
  153. 3.
    Braun R, Kirchner H (1986) Klinische Bedeutung von lnfektionen mit Herpes-simplex-Viren. Dtsch Arztebl 37/83: 2433–2438Google Scholar
  154. 4.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  155. 5.
    Gilbert J, Drehs MM, Weinberg JM (2001) Topical imiquimod for acyclovir-unresponsive herpes simplex virus 2 infection. Arch Dermatol137/8: 1015–1017Google Scholar
  156. 6.
    Doerr HW, Rabenau H (1996) Dermatotrope Herpesviren, lnfektionsbiologie, Epidemiologie und Diagnostik. Chemotherapie J 1: 1–11Google Scholar
  157. 7.
    Fleming DT, McQuillan GM, Johnson RE et al. (1997) Herpes simplex type 2 in the United States, 1976 to 1994. N Eng J Med 337: 1105–1111CrossRefGoogle Scholar
  158. 8.
    Glosch St (1996) Herpes-simplex-Virus-lnfektionen. Derm 2: 474–480Google Scholar
  159. 9.
    Goldmeier D (1980) Proctitis and herpes simplex virus in homosexual men. Br J Vener Dis 56: 111–114PubMedGoogle Scholar
  160. 10.
    Goodell SE et al. (1983) Herpes simplex virus proctitis in homosexual men. N Engl J Med 308: 868–87lPubMedCrossRefGoogle Scholar
  161. 11.
    Gross G (1994) Herpes genitalis. Wegbereiter fUr eine HIV-Ubertragung. TW Dermatologie 24: 150–155Google Scholar
  162. 12.
    Gross G (1995) Klinik und Therapie der HSV1 und HSV2 lnfektion. In: Ring J, Zander AR, Malin J-p (Hrsg) Diagnostik und Therapie von Herpes Virus-Infektionen. Braun, S 41–62Google Scholar
  163. 13.
    Lautenschlager S, Eichmann A (2001) The heterogenous clinical spectrum of genital herpes. Dermatology 202/3: 211–219CrossRefGoogle Scholar
  164. 14.
    Lautenschlager S, Kempf W (2000) Herpes genitalis. Hautarzt 51:964–983PubMedCrossRefGoogle Scholar
  165. 15.
    Mahler V, Schuler G (2001) Therapie von VarizellaZoster-und Herpes-simplex-Virus-bedingten Erkrankungen. Teil 1: Virustatische Agenzien. Hautarzt 52: 464–471PubMedCrossRefGoogle Scholar
  166. 16.
    Mahler V, Schuler G (2001) Therapie von Varizella-Zoster-und Herpes-simplex-Virus-bedingten Erkrankungen. Teil 2: Hinweise zur DurchfUhrung und Indikationen zur virustatischen Therapie. Hautarzt 52: 554–574PubMedCrossRefGoogle Scholar
  167. 17.
    McKeough MB, Spruance SL (2001) Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection. Arch Dermatol137/9: 1153–1158Google Scholar
  168. 18.
    Mindel A (1989) Herpes simplex virus. Springer, London Berlin Heidelberg New York Paris TokyoCrossRefGoogle Scholar
  169. 19.
    Mindel A et al. (1988) Dosage and safety of long-term suppressive aciclovir therapy for recurrent genital herpes. Lancet I/8591: 926–928CrossRefGoogle Scholar
  170. 20.
    Nahass GT, Goldstein BA, Zhu WY, Serfling U, Penneys NS, Leonardi CL (1992) Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infection. JAMA 268/18: 2541–2544CrossRefGoogle Scholar
  171. 21.
    Moseley RC, Corey L, Benjamin D, Winter C, Remington ML (1981) Comparison of viral isolation, direct immunofluorescence, and direct immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol 13/5: 913–918Google Scholar
  172. 22.
    Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  173. 23.
    Petersen EE, Doerr HW, Gross G, Petzoldt D, Weiss enbacher ER, Wutzler P (1999) Der Herpes genitalis. Dtsch Arztebl 38: A2358–A2364Google Scholar
  174. 24.
    Preiser W, Berger A, Doerr HW (2000) Therapie viraler Erkrankungen. Dtsch Arztbl 50: A3433–A3440Google Scholar
  175. 25.
    Reimlinger St, Wassilew S (1984) Primarer Herpes analis. Der Hautarzt 35: 263–264Google Scholar
  176. 26.
    Rufli Th (1983) Sexuell iibertragene anorektale Infektionskrankheiten. Schweiz Rundschau Med (Praxis) 72: 1000–1008Google Scholar
  177. 27.
    Samarasinghe PL, Oates IK, MacLennan IPB (1979) Herpetic proctitis and sacral radiculomyelopathy-a hazard for homosexual man. Br Med J II: 360–365Google Scholar
  178. 28.
    Schmitt SL, Wexner SD, Nogueras JJ, Jagelmann DG (1993) Is aggressive management of perianal ulcers inhomosexual HIV-positive men justified? Dis Colon Rectum 36/3: 240–246CrossRefGoogle Scholar
  179. 29.
    Stary A (1985) Neuere diagnostische Methoden beim Herpes simplex. Z Hautkrankht 60/22: 1767–1779Google Scholar
  180. 30.
    Wehr A (1997) Herpes genitalis-die unterschatzte Erkrankung? Beilage in Der Hautarzt 48/1: 1–8Google Scholar
  181. 31.
    Winceslaus J, Jones PA (1997) Genital herpes masquerading as anal fissures. J R Coli Surg Edinb 42/4: 276–277Google Scholar
  182. 32.
    Wolf MH (1986) Herpes simplex-Virus-Infektion. Diagnose Labor 36: 104–111Google Scholar
  183. 33.
    Zimmer D (1995) Herpes genitalis: Emotionale Unterstiitzung bessert Lebensqualitat. Fortschr Med 113/19: 44Google Scholar
  184. 1.
    Christian CW, Singer ML, Crawford JE, Durbin D (1997) Perianal herpes zoster presenting as suspected child abuse. Pediatrics 99/4: 608–610CrossRefGoogle Scholar
  185. 2.
    Degreef H. et al. (1994) Famciclovir, a new oral antiherpes drug: results of the first controlled chemical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Antimicrobiology Agents Internat 4: 241–246CrossRefGoogle Scholar
  186. 3.
    Eis-Hübinger AM et al. (1992) Nachweis von VarizellaZoster-Virus-Infektionen mittels Polymerasekettenreaktion. Hautarzt 43: 767–771PubMedGoogle Scholar
  187. 4.
    Engst R (1989) Therapie des Zoster. Z Hautkrankht 64: 848–850Google Scholar
  188. 5.
    Gross G (1997) Zoster-Manifestationsformen an der Haut, Komplikationen und Therapie. Dtsch Med Wochenschr 122: 132–139PubMedCrossRefGoogle Scholar
  189. 6.
    Jellinek EH, Selby Tulloch W (1976) Herpes zoster with dysfunction of bladder and anus. Lancet 2: 1219–1222PubMedCrossRefGoogle Scholar
  190. 7.
    Jucgla A, Badell A, Ballesta C, Arbizu T (1996) Colonic pseudo-obstruction: a complication of herpes zoster. Br J Dermatol134/4: 788–790CrossRefGoogle Scholar
  191. 8.
    Kint A (1987) Neuere therapeutische Moglichkeiten bei Herpes simplex und Herpes zoster. Aktuel Dermatol 13: 241–242Google Scholar
  192. 9.
    Kempf W, Lautenschlager S (2001) Infektionen mit dem Varizella-zoster-Virus. Hautarzt 52: 359–376PubMedCrossRefGoogle Scholar
  193. 10.
    Mahler V, Schuler G (2001) Therapie von VarizellaZoster-und Herpes-simplex-Virus-bedingten Erkrankungen. Teil 1: Virustatische Agenzien. Hautarzt 52: 464–471PubMedCrossRefGoogle Scholar
  194. 11.
    Mahler V, Schuler G (2001) Therapie von VarizellaZoster-und Herpes-simplex-Virus-bedingten Erkrankungen. Teil 2: Hinweise zur Durchftihrung und Indikationen zur virustatischen Therapie. Hautarzt 52:554–574PubMedCrossRefGoogle Scholar
  195. 12.
    Menuck LS et al. (1976) Colonic Changes of Herpes Zoster. AJR 127:273–276PubMedGoogle Scholar
  196. 13.
    Nahass GT, Goldstein BA, Zhu WY, Serfling U, Penneys NS, Leonardi CL (1992) Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infection. JAMA 268/18: 2541–2544Google Scholar
  197. 14.
    Pue MA, Benet LZ (1993) Pharmacokinetics of famciclovir in man. Antiviral Chern Chemother 4 [Suppl] 1Google Scholar
  198. 15.
    Rowbotham MC (1992) Treatment of postherpetic neuralgia. Semin Dermatol 3: 218–225Google Scholar
  199. 16.
    Sauerbrei A, Sommer M, Wutzler P (1999) Virologische Diagnostik des Herpes zoster. Hautarzt 50: 873–878PubMedCrossRefGoogle Scholar
  200. 17.
    Soltz-Szotz J (1987) 3 Jahre Erfahrung in der Zostertherapie mit Aciclovir und Corticosteroiden. Aktuel Dermatol 13: 245–246Google Scholar
  201. 18.
    Yamanashi T, Yasuda K, Sakakibara R, Hattori T, Uchiyama T, Minamide M, Ito H (1998) Urinary retention due to herpes virus infections. Neururol Urodyn 17/6: 613–619Google Scholar
  202. 19.
    Wood MJ et al. (1994) A randomized trial of aciclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 330: 896–900PubMedCrossRefGoogle Scholar
  203. 1.
    Bunney MH (1969) Molluscum contagiosum of the sole: A rare diagnosis or a rare condition. Br J Dermatol 81: 623–625PubMedCrossRefGoogle Scholar
  204. 2.
    Barba AR, Kapoor S, Berman B (2001) An open label safety study of topical imiquimod 5 % cream in the treatment of molluscum contagiosum in children. Dermatol Online J 7/1: 20Google Scholar
  205. 3.
    Calista D (2000) Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study. J Eur Acad Dermatol Venereol 14/6: 484–488CrossRefGoogle Scholar
  206. 4.
    Diven DG (2001) An overview of poxiviruses. J Am Acad Dermatol4411:1–16CrossRefGoogle Scholar
  207. 5.
    Epstein E (2001) Cantharidin therapy for molluscum contagiosum in children. J Am Acad Dermatol 45/4: 638CrossRefGoogle Scholar
  208. 6.
    Hammes S, Greve B, Raulin C (2001) Mollusca contagiosa. Hautarzt 52: 38–42PubMedCrossRefGoogle Scholar
  209. 7.
    Hawley TG (1970) The natural history of molluscum contagiosum in Fijian children. II. Hyg Camb 68: 631–632CrossRefGoogle Scholar
  210. 8.
    Hengge UR, Esser S, Schultewolter T, Behrendt C, Meyer T, Stockfleth E, Goos M (2000) Self-administered topical 5 % imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 143/5: 1026–1031CrossRefGoogle Scholar
  211. 9.
    Hicks CB, Myers SA, Giner J (1997) Resolutiion of intractable molluscum contagiosum in a human immunodeficiency virus-infected patient after institution of antiretroviral therapy with ritonavir. Clin Infect Dis 24/5: 1023–1025CrossRefGoogle Scholar
  212. 10.
    Hund G (1975) Vitamin-A-Saure-Therapie von Mollusca contagiosa bei Haemophilie. A Z Hautkrankht 50: 291–292Google Scholar
  213. 11.
    Humi MA, Bohlen L, Furrer H, Braathen LR (1997) Complete regression of giant molluscum contagiosum lesions in an HIV-infected patient following combined antiretroviral therapy with saquinavir, zidovudine and lamivudine. AIDS 11/14: 1784–1785Google Scholar
  214. 12.
    Ingraham HJ, Schoenleber DB (1998) Epibulbar molluscum contagiosum. Am J Ophthalmol 125/3: 394–396CrossRefGoogle Scholar
  215. 13.
    Liota E, Smith KJ, Buckley R, Menon P, Skelton H (2000) Imiquimod therapy for molluscum contagiosum. J Cutan Med Surg 4/2: 76–82Google Scholar
  216. 14.
    Pauly ChR, William MA, Henry EJ (1978) Atopic dermatitis impaired cellular immunity and molluscum contagiosum. Arch Dermatol114: 391–393PubMedCrossRefGoogle Scholar
  217. 15.
    Romiti R, Ribeiro AP, Romiti N (2000) Evaluation of the effectiveness of 5 % potassium hydroxide for the treatment of mollusum contagiosum. Pedriatr Dermatol 17/6: 495CrossRefGoogle Scholar
  218. 16.
    Schwartz JJ, Myskowski PL (1992) Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol27/4: 583–588CrossRefGoogle Scholar
  219. 17.
    Simon M jr, Wieser E (1980) Ungewohnliche Molluscum contagiosum-Infektion bei Sarkoidose. Hautarzt 31: 341–343PubMedGoogle Scholar
  220. 18.
    Whitaker SB, Wiegand SE, Budnick SD (1991) Intraoral molluscum contagiosum. Oral Surg Oral Med Oral Pathol 72/3: 334–336CrossRefGoogle Scholar
  221. 1.
    Berth-Jones, Hutchinson PE (1992) Modern treatment of warts: cure rates at 3 and 6 months. Br J Dermatol 127:262–265PubMedCrossRefGoogle Scholar
  222. 2.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  223. 3.
    Egawa K (1994) New types of human papillomaviruses and intracytoplasmatic inclusion bodies: a classification of inclusion warts according to clinical features, histology and associated HPV types. Br J Dermatol 130: 158–166PubMedCrossRefGoogle Scholar
  224. 4.
    Gross G (1987) Lesions of the male and female external genitalia associated with human papillomaviruses. In: Syrjanen K, Gissmann L, Koss LG (eds) Papillomaviruses and human disease. Springer, Berlin Heidelberg New York Tokyo, pp 197-234Google Scholar
  225. 5.
    Gross G (1997) Therapy-skin warts. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 375Google Scholar
  226. 6.
    Gross G, Jablonska S (1997) Skin warts: morphology and histology. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 243Google Scholar
  227. 7.
    Gross G, Pfister H, Hagedorn M, Stahn R (1982) Effect of oral aromatic retinoid (Ro 10-9359) in human papilloma virus-2-induced common warts. Dermatol 78: 160–164Google Scholar
  228. 8.
    Grußendorf-Conen E-J (1990) Humanpathogene Papillomviren und deren Beziehungen zur Onkogenese. Hautarzt 41: 658–661PubMedGoogle Scholar
  229. 9.
    Grußendorf-Conen E-J (1993) Humanpathogene Papillomviren in der Genese des Zervixkarzinoms. Fortschr Med 9: 145–146Google Scholar
  230. 10.
    Grußendorf-Conen E-J (1993) Behandlung von HPVinduzierten klinischen Veranderungen. Dtsch Arztebl 90: A 1 2326–2330Google Scholar
  231. 11.
    GruBendorf-Conen E-J (1993) HPV in der Onkogenese. Hautarzt 44: 427–431Google Scholar
  232. 12.
    Jablonska S, Majewski S, Obalek S, Orth G (1997) Cutaneous warts. Clin Dermatol15/3: 309–319CrossRefGoogle Scholar
  233. 13.
    Kimmig W, Kroger HJ, Hicks R, Breitbart W (1987) Ultraschallkontrollierte Nd-YAG-Lasertherapie von Viruspapillomen. Aktuel Dermatol13: 231–233Google Scholar
  234. 14.
    Lentner A, Wienert V (1996) Perianale Condylomata plana. Z Hautkrankht 8: 630–632Google Scholar
  235. 15.
    Moy R, Eliezri YD (1994) Significance of human papillomavirus-induced squamous cell carcinoma to dermatologists. Arch Dermatol 130: 235–237PubMedCrossRefGoogle Scholar
  236. 16.
    Pfau A et al. (1994) Nd: YAG laser hyperthermia in the treatment of recalcitrant verrucae vulgares. (Regensburg's technique). Acta Derm Venereol 74: 212–214PubMedGoogle Scholar
  237. 17.
    Robson KJ, Cunningham NM, Kruzan KL, Patel DS, Kreiter CD, O’Donnell MJ, Arpey CJ (2000) Pulsed-dye laser versus conventional therapy in the treatment of warts: a prospective randomized trial. J Am Acad Dermatol 43: 275–280PubMedCrossRefGoogle Scholar
  238. 18.
    Schneider A, Wagner D (1993) Infektionen der Frau mit genitalem humanem Papillomvirus. Dtsch Arztebl 10: A 1 730–732Google Scholar
  239. 19.
    Stein E (1985) Warzen. Z Allgemeinmed 13: 3–5Google Scholar
  240. 20.
    Tyring SK (2000) Human papillomavirus infections: epidemiology, pathogenesis, and host immune response. JAm Acad Dermatol43: S18–26CrossRefGoogle Scholar
  241. 21.
    Villiers EM de (1992) Laboratory techniques in the investigation of human papillomavirus infection. Genitourin Med 68: 50–54PubMedGoogle Scholar
  242. 22.
    Wimmershoff MB, Scherer K, Baumler W, Hohenleutner U, Landthaler M (2001) Behandlung von therapieresistenten Verrucae vulgares mit dem lang-gepulsten Farbstofflaser. Hautarzt 52: 701–704PubMedCrossRefGoogle Scholar
  243. 23.
    Zur Hausen H (1977) Human papillomaviruses and their possible role in squamous cell carcinomas. Current Top Microbiol Immunol 78: 1–30CrossRefGoogle Scholar
  244. 24.
    Zur Hausen H (1982) Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events? Lancet II: 1370–1372Google Scholar
  245. 25.
    Zur Hausen H (1987) Papillomaviruses in human cancer. Cancer 59: 1692–1696PubMedCrossRefGoogle Scholar
  246. 1.
    Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AMWF) (1999) Leitlinie zum Krankheitsbild der Feigwarzen in der anorektalen Region. Leitlinien der Deutschen Dermatologischen Gesellschaft. AWMF online, awmf@uni-duesseldorf.deGoogle Scholar
  247. 2.
    Beersiek E, Gross E, Eigler FW (1980) Die chirurgische Behandlung analer und intraanaler Condylomata acuminata. Coloproctology 6: 400–402Google Scholar
  248. 3.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  249. 4.
    Brown TJ, Yen-Moore A, Tyring SK (1999) An overview of sexually transmitted diseases. Part II. J Am Acad Dermatol4115: 661–677CrossRefGoogle Scholar
  250. 5.
    Buschke A, Löwenstein L (1925) Über carcinomähnliehe Condylomata acuminata des Penis. Klin Woehensehr 4: 1726CrossRefGoogle Scholar
  251. 6.
    Edwards L, Ferenczy A, Eron L et al. (1998) Self-administered topical 5 % imiquimod cream for extern al anogenital warts. Arch Dermatol 134/1: 25–30CrossRefGoogle Scholar
  252. 7.
    Elsner P, Hartmann AA, Wecker J (1987) Condylomata acuminata-assoziierte STD-Infektionen der Urethra des Mannes. Eine vergleichende epidemiologische Studie. Hautarzt 38: 26–30PubMedGoogle Scholar
  253. 8.
    Firlbeck G, Rassner G (1987) Behandlung von Condylomata acuminata mit systemisch applizierten rekombinanten Interferon gamma. Z Hautkrankht 62/17: 1280–1287Google Scholar
  254. 9.
    Gross G (1984) Condylomata acuminata und andere Papillomvirus-assoziierte Erkrankungen der Urogenital-und Analregion. Infekt Immun 12: 261–265Google Scholar
  255. 10.
    Gross G (1987) Lesions of the male and female external genitalia associated with human papillomaviruses. In: Syrjänen K, Gissmann L, Koss LG (eds) Papillomaviruses and human disease. Springer, Berlin Heidelberg New York Tokyo, pp 197–234CrossRefGoogle Scholar
  256. 11.
    Gross G (1988) HPV-Infektionen mit Essigsäure aufspüren. Sexualmedizin 17: 59–62Google Scholar
  257. 12.
    Gross G (2001) Condylomata acuminata und andere HPV-assoziierte Krankheitsbilder des Genitale und der Harnröhre. Leitlinie der Deutschen STD-Gesellschaft (DSTDG). Hautarzt 52: 405–410PubMedCrossRefGoogle Scholar
  258. 13.
    Gross G (2001) HPV-Infektionen. In: Petzoldt D, Gross G (Hrsg) Diagnostik und Therapie sexuell übertragbarer Krankheiten-Leitlinien der Deutschen STD-GeseIlschaft. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  259. 14.
    Gross G (2001) Klinik und Therapie anogenitaler Warzen und papillomvirusassoziierter Krankheitsbilder. Hautarzt 52: 6–17PubMedCrossRefGoogle Scholar
  260. 15.
    Gross G, Pfister H, Hagedorn M, Gissmann L (1982) Correlation between human papillomavirus type (HPV) and histology of warts. J Invest Dermatol 78: 160–164PubMedCrossRefGoogle Scholar
  261. 16.
    Gross G et al. (1985) Papillomavirus infection of the anogenital region: Correlation between histology, clinical picture and virus type. Proposal of a new nomenclature. J Invest Dermatol85: 147–152PubMedCrossRefGoogle Scholar
  262. 17.
    Gross G, Roussaki A, Brzoska J (1988) Low doses of systemically administered recombinant interferongamma effective in the treatment of genital warts. J Invest Dermatol 90:242Google Scholar
  263. 18.
    Gross G, Roussaki A, Baur S, Wiegand M, Mescheder A (1996) Systematically administered interferon alfa-2aprevents recurrence of condylomata acuminata following C02-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial. Genitourin Med 72/1: 71Google Scholar
  264. 19.
    Gross G, Krogh G von, Barrasso R (1997) Therapy-genitoanallesions. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 389Google Scholar
  265. 20.
    Hengge UR, Benninghoff B, Ruzicka T, Goos M (2001) Topical immunomodulators-progress towards treating inflammation, infection, and cancer. Lancet Infect Dis 1: 189–198PubMedCrossRefGoogle Scholar
  266. 21.
    Hohenleutner U et al. (1989) Condylomata acuminata gigantea (Buschke-Löwenstein-Tumor). Dtsch Med Wochenschr 113: 985–987CrossRefGoogle Scholar
  267. 22.
    Hohenleutner U, Landthaler M. Braun-Falco O (1990) Postoperative adjuvante Therapie mit Interferon-Alfa-2 b nach Laserchirurgie von Condylomata acuminata. Hautarzt 41/10: 545–548Google Scholar
  268. 23.
    Krogh G von (1976) 5-Fluorouracil cream in the successful treatment of therpeutical refractory condylomata acuminata of the urinary meatus. Acta Derm Venereol (Stockh) 56:297–301Google Scholar
  269. 24.
    Krogh G von, Gross G, Barrasso R (1997) Warts and HPV-related squamous cell tumors of the genitoanal area in adults. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 259Google Scholar
  270. 25.
    Krumm D (1987) Ergebnisse einer konservativen Therapie von Condylomata acuminata. Darstellung anhand eines Falles von analen Condylomen. Dt Derm 35/3: 269–275Google Scholar
  271. 26.
    Landthaler M (1994) Anogenitale Feigwarzen: Behandlung heute aussichtsreicher. Med Trib 29:8Google Scholar
  272. 27.
    Luchtefeld MA (1994) Perianal condylomata acuminatao Surg Clin North Am 74/6: 1327–1338Google Scholar
  273. 28.
    Prasad J, Isbister WH (1995) Perianale Condylomata acuminata. Coloproctology 3: 111–113Google Scholar
  274. 29.
    Rock B, Shabh KV, Farmer ER (1992) A morphologic, pathologic, and virologic study of anogenital warts in men. Arch Dermatol 128/4: 495–500CrossRefGoogle Scholar
  275. 30.
    Simmons PD (1981) Podophyllin 10% and 25% in the treatment of ano-genital warts. A comparative doubleblind study. Br J Vener Dis 57: 208–209PubMedGoogle Scholar
  276. 31.
    Stein E (1983) Therapiemethoden bei Vorliegen von Condylomata acuminata. Med Trib 6: 37–38Google Scholar
  277. 32.
    Stein E (1984) Condylomata acuminata. Der informierte Arzt 7: 6–10Google Scholar
  278. 33.
    Thomson JPS et al. (1978) The treatment of perianal and anal condylomata acuminata: a new operative technique. J R Soc Med 71: 180–185PubMedGoogle Scholar
  279. 34.
    Wagner G, Kowalzick L (1992) Erfolgreiche systemische Behandlung vorher therapieresistenter Condylomata acuminata mit rekombinantem Gamma-Interferon. Aktuel Dermatol18: 180–182Google Scholar
  280. 35.
    Weismann K, Kassis V (1982) Behandlung von Condylomata acuminata mit 0,5 %iger 5-Fluorouracil-Lösung. Eine doppelblindklinische Untersuchung. Z Hautkrankht 57: 810–816Google Scholar
  281. 36.
    Wienert V (1999) Krankheitsbild der Feigwarzen in der anorektalen Region. Coloproctology 21: 38–41CrossRefGoogle Scholar
  282. 37.
    Wienert V (2001) Feigwarzen in der anorektalen Region. In: Korting HC, Callies R, Reusch M, Schlaeger M, Schöpf E, Sterry W (Hrsg) Dermatologische Qualitätssicherung-Leitlinien und Empfehlungen, 2. Aufl. Zuckschwerdt, München, S 128–133Google Scholar
  283. 38.
    Zur Hausen H (1989) Papilloma virus es in anogenital cancer as a model to understand the role of virus es in human cancers. Cancer Res 49: 4677–4681PubMedGoogle Scholar
  284. 1.
    Braun-Fako O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  285. 2.
    Civatte J (1983) Die falschen Formen von Morbus Bowen an den Genitalschleimhäuten. Hautarzt 34: 298–305PubMedGoogle Scholar
  286. 3.
    Fierlbeck G (1993) Topische Interferon-Therapie: Kritische Bewertung. In: Braun-Falco O, Plewig G, Meurer M (Hrsg) Fortschritte der praktischen Dermatologie und Venerologie, Bd. 13. Springer, Berlin Heidelberg New York Tokyo, S 407–412CrossRefGoogle Scholar
  287. 4.
    Friedrich EG (1972) Reversible vulvar atypia. A case report. Obstet Gynecol 39: 173–181PubMedGoogle Scholar
  288. 5.
    Gross G (1987) Lesions of the male and female extern al genitalia associated with human papillomaviruses. In: Syrjänen K, Gissmann L, Koss LG (eds) Papillomaviruses and human disease. Springer, Berlin Heidelberg New York Tokyo, pp 197–234Google Scholar
  289. 6.
    Gross G, Barrasso R (1997) Human papillomavirus infection. A clinical atlas. Ullstein/Mosby, München ChicagoGoogle Scholar
  290. 7.
    Gross G et al. (1985) Papillomavirus infection of the anogential region: Correlation between histology, clinical picture and virus type. Proposal of a new nomenclature. J luvest Dermatol85: 147–152CrossRefGoogle Scholar
  291. 8.
    Gross G et al. (1985) Bowenoid Papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences in bowenoid papulosis. Arch Dermatol121: 858–863PubMedCrossRefGoogle Scholar
  292. 9.
    Gross G, Wagner D, Hauser-Brauner B, Ikenberg H, Gissmann L (1985) Bowenoide Papulose und Carcinoma in situ der Cervix uteri bei Sexualpartnern. Ein Beispiel für die Übertragbarkeit der HPV-16-lnfektion. Hautarzt 36/8:465–469Google Scholar
  293. 10.
    Gross G, Krogh G von, Barrasso R (1997) Therapy-genitoanallesions. In: Groß G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 389Google Scholar
  294. 11.
    Grussendorf-Conen EJ (1988) HPV-16-induzierte pigmentierte bowenoide Papulose am Hals. Aktuel Dermatol14: 317–319Google Scholar
  295. 12.
    Hagedorn M, Faber M (1979) Multizentrisches bowenoides Akanthom-ein neues Krankheitsbild im genito-analen Bereich. Aktuel Dermatol 5: 185–190Google Scholar
  296. 13.
    Hauser B, Gross G, Schneider A, Villiers EM de, Gissmann L, Wagner D (1985) HPV-16-related Bowenoid papulosis. Lancet 2/8446: 106CrossRefGoogle Scholar
  297. 14.
    Höpfl R, Guger M, Widschwendter A (2001) Humane Papillomviren und ihre Rolle bei der Karzinogenese. Hautarzt 52: 834–846PubMedCrossRefGoogle Scholar
  298. 15.
    Ikenberg H, Gissmann L, Gross G, Grussendorf-Conen EI, zur Hausen H (1983) Human papillomavirus type 16 related DNA in genital Bowen's disease and in Bowenoid Papulosis. Int J Cancer 32: 563–565PubMedCrossRefGoogle Scholar
  299. 16.
    Kopf AW, Bart RS (1977) Tumor conference No 11. Multiple bowenoid papules of the penis: a new entity? J Dermatol Surg Oncol 3: 265–269PubMedGoogle Scholar
  300. 17.
    Lloyd KM (1970) Multicentric pigmented Bowen's disease of the groin. Arch Dermatol101: 48–51Google Scholar
  301. 18.
    Majewski S, Jablonska S (1997) Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 36/5: 659 ff.CrossRefGoogle Scholar
  302. 19.
    Materna U, Zabel M, Hettwer H (1996) Frühinvasives Plattenepithelkarzinom bei bowenoider Papulose (VIN III) Triggerung durch virale (HPV 16-) und bakterielle (Chlamydien-) Infektionen? Z Hautkrankht 1: 15–20Google Scholar
  303. 20.
    Palefsky J (1997) HPV related disease in immunosuppressed individuals. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 227Google Scholar
  304. 21.
    Schwartz RA, Janninger CK (1991) Bowenoid papulosis. J Am Acad Dermatol 24: 261–264PubMedCrossRefGoogle Scholar
  305. 22.
    Wade TR, Kopf AW, Ackerman AB (1979) Bowenoid papulosis of the Genitalia. Arch Dermatol115:306–308PubMedCrossRefGoogle Scholar
  306. 23.
    Wigbels B, Luger T, Metze D (2001) Imiquimod-eine neue Therapiemöglichkeit der bowenoiden Papulose? Hautarzt 52/2: 128–131CrossRefGoogle Scholar
  307. 24.
    Zachow KR, Ostrow RS, Bender M et al. (1982) Detection of human papillomavirus DNA in anogenital neoplasias. Nature 300: 771–773PubMedCrossRefGoogle Scholar
  308. 1.
    Andersen SLC, Nielsen A, Reymann F (1973) Relationship between Bowen disease and internal malignant tumors. Arch Dermatol 108: 367PubMedCrossRefGoogle Scholar
  309. 2.
    Beck SC (1933) Epitheliome. In: Jadassohn J (Hrsg) Handbuch der Haut-und Geschlechtskrankheiten. Bd XII/3. Springer, Berlin, S433Google Scholar
  310. 3.
    Berger BW, Hori Y (1978) Multicentric Bowen's disease of the genitalia. Arch Dermatol 114: 1698PubMedCrossRefGoogle Scholar
  311. 4.
    Bowen JT (1912) Precancerous dermatoses: A study of 2 cases of chronic atypical epithelial proliferation. J Cutan Dis 30: 241Google Scholar
  312. 5.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  313. 6.
    Cleary RK, Schaldenbrand JD, Fowler JJ, Schuler JM, Lampman RM (2000) Treatment options for perianal Bowen's disease: survey of American Society of Colon and Rectal Surgeons Members. Am Surg 6617:686–688Google Scholar
  314. 7.
    Gebbers J-O, Laissue J-A (1984) Pathologie der Analtumoren. Schweiz Rundschau Med (Praxis) 27: 847–862Google Scholar
  315. 8.
    Graham JH, Helwig EB (1959) Bowen's disease and its relationship to systemic cancer. Arch Dermatol 80: 133CrossRefGoogle Scholar
  316. 9.
    Gross G (1987) Lesions of the male and female external genitalia associated with human papillomaviruses. In: Syrjänen K, Gissmann L, Koss LG (eds) Papillomaviruses and human disease. Springer, Berlin Heidelberg New York Tokyo, p 197CrossRefGoogle Scholar
  317. 10.
    Gross G, Krogh G von, Barrasso R (1997) Therapy-genitoanallesions. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 389Google Scholar
  318. 11.
    Höpfl R, Guger M, Widschwendtner A (2001) Humane Papillomviren und ihre Rolle bei der Karzinogenese. Hautarzt 52: 834–846PubMedCrossRefGoogle Scholar
  319. 12.
    Ikenberg H, Gissmann L, Gross G, Grussendorf-Conen EJ, zur Hausen H (1983) Human papillomavirus type-16-related DNA in genital Bowen's disease and in bowenoid papulosis. Int J Cancer 32: 563–565PubMedCrossRefGoogle Scholar
  320. 13.
    Jaeger AB, Gramkow A, Hjalgrim H, Melbye M, Frisch M (1999) Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients. Arch Dermatol135/7: 790–793CrossRefGoogle Scholar
  321. 14.
    Krogh G von, Gross G, Barrasso R (1997) Warts and HPV-related squamous cell tumors of the genitoanal area in adults. In: Gross G, Krogh G von (eds) Human papillomavirus infections in dermatovenerology. CRC, Boca Raton, p 259Google Scholar
  322. 15.
    Majewski S, Jablonska S (1997) Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 36/5: 659–685. 659-685CrossRefGoogle Scholar
  323. 16.
    Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC (1997) Perianal Bowen's disease: a clinicopathologic study of 47 patients. Dis Colon Rectum 40/11: 1286–1293Google Scholar
  324. 17.
    Nordin P, Stenquist B, Hansson BG (1994) Joint occurence of human papillomavirus type 16 DNA in Bowen's disease on a finger and in dysplasia of the vulva and the uterine cervix. Br J Dermatol131/5: 740CrossRefGoogle Scholar
  325. 18.
    Runfola MA, Weber TK, Rodriguez-Bigas MA, Dougherty TJ, Petrelli NJ (2000) Photodynamic therapy for residual neoplasms of the perianal skin. Dis Colon Rectum 43/4: 499–502CrossRefGoogle Scholar
  326. 19.
    Sarmiento JM, Wolff BG, Burgart LJ, Frizelle FA, Il-strup DM (1997) Perianal Bowen's disease: associated tumors, human papillomavirus, surgery, and other controversies. Dis Colon Rectum 40/8: 912–918CrossRefGoogle Scholar
  327. 20.
    Schmidt K-U, Wiskemann A, Mensing H (1986) Etretinat und 5-Fluorouracil bei intraanalem M. Bowen. Der Hautarzt 37:278–280Google Scholar
  328. 21.
    Thestrup-Pedersen K et al. (1988) Morbus Bowen. A description of the disease in 617 patients. Acta Dermatol Venerol (Stockh) 68: 236–239Google Scholar
  329. 1.
    Buschke A, Löwenstein L (1925) Über carcinomähnliche Condylomata acuminata des Penis. Klin Wochenschr 4: 1726CrossRefGoogle Scholar
  330. 2.
    Buschke A, Löwenstein L (1932) Über die Beziehungen von spitzen Kondylomen zu Karzinomen des Penis. Dtsch Med Wochenschr 58:809CrossRefGoogle Scholar
  331. 3.
    Chu QD, Vezeridis MP, Libbey NP, Wanebo HJ (1994) Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum 37/9: 950–957CrossRefGoogle Scholar
  332. 4.
    Cosman BC, O'Grady TC, Pekarske S (2000) Verrucous carcinoma arising in hidrademitis suppurativa. Int J Colorectal Dis 15:342–346PubMedCrossRefGoogle Scholar
  333. 5.
    Cuesta KH, Palazzo JP, Mittal KR (1998) Detection of human papillomavirus in verrucous carcinoma from HIV-seropositive patients. J Cutan Pathol 25/3: 165–170CrossRefGoogle Scholar
  334. 6.
    Hohenleutner U et al. (1989) Condylomata acuminata gigantea (Buschke-Löwenstein-Tumor). Dtsch Med Wochenschr 113: 985–987CrossRefGoogle Scholar
  335. 7.
    Höpfl R, Guger M, Widschwendtner A (2001) Human Papillomviren und ihre Rolle bei der Karzinogenese. Hautarzt 52: 834–846PubMedCrossRefGoogle Scholar
  336. 8.
    Löwenstein L (1939) Carcinoma-like Condylomata acuminata of the penis. Surg Clin N Am 23: 789Google Scholar
  337. 9.
    Majewski S, Jablonska S (1997) Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 3615: 659–685CrossRefGoogle Scholar
  338. 10.
    Noel JC, Sornin De Leysat C, Peny MO, De Stadt J van, Fayt I, De Dobbeleer G (2001) Warty carcinoma of the anus: a variant of a squamous cell carcinoma associated with anal intraepithelial neoplasia and human papillomavirus infection. Dermatology 203/3: 262–264Google Scholar
  339. 11.
    Richter M et al. (1995) Plattenepithelkarzinom in einem perianalen Buschke-Löwenstein-Tumor. Coloproctology 5: 236–239Google Scholar
  340. 12.
    Sobrado CW, Mester M, Nadalin W, Nahas SC, Bocchini SF, Habr-Gama A (2000) Radiation-induced total regression of a highly recurrent giant perianal condyloma. Report of a case. Dis Colon Rectum 43: 257–260PubMedCrossRefGoogle Scholar
  341. l3.
    Vandeweyer E, Sales F, Deraemaecker R (2001) Cutaneous verrucous carcinoma. Br J Plast Surg 54/2: 168–170CrossRefGoogle Scholar
  342. 1.
    Agathos M (1994) Skabies. Hautarzt 45: 889–903PubMedCrossRefGoogle Scholar
  343. 2.
    Brown S, Becher J, Brady W (1995) Treatment of ectoparasitic infections: review of the English-language literature. Clin Infect Dis 20 (Suppl 1): S104–109CrossRefGoogle Scholar
  344. 3.
    Burkhart CG, Burkhart CN, Burkhart KM (2000) An epidemiologic and therapeutic reassessment of scabies. Cutis 65/4: 233–240Google Scholar
  345. 4.
    Bums DA (1991) The treatment of human ectoparasite infection. Br J Dermatol 125: 89–93Google Scholar
  346. 5.
    Estes SA (1993) Therapy of scabies: nursing hornes, hospitals, and the homeless. Semin Dermatol12: 26–33PubMedGoogle Scholar
  347. 6.
    Föster-Holst R, Rufli T, Christophers E (2000) Die Skabiestherapie unter besonderer Berücksichtigung des frühen Kindesalters, der Schwangerschaft und Stillzeit. Hautarzt 51: 7–13CrossRefGoogle Scholar
  348. 7.
    Haas N (1987) Eine einfache vitalmikroskopische Hilfe zum Nachweis von Skabiesmilben. Z Hautkrankht 62: 1395–1398Google Scholar
  349. 8.
    Haustein U-F (1991) Pyrethrine und Pyrethroide (Permethrin) bei der Behandlung von Skabies und Pediculosis. Hautarzt 42: 9–15PubMedGoogle Scholar
  350. 9.
    Haustein U-F, Franz H (2001) Antiparasitika. In: Korting HC, Sterry W (Hrsg) Therapeutische Verfahren in der Dermatologie: Dermatika und Kosmetika. Blackwell, Berlin, S.337–345Google Scholar
  351. 10.
    Jung EG (1980) Scabies. Aktuel Dermatol 6: 77–84Google Scholar
  352. 11.
    Madan V, Jaskiran K, Gupta U, Gupta DK (2001) Oral ivermectin in scabies patients: a comparison with 1 % topicallindane lotion. J Dermato128/9: 481–484Google Scholar
  353. 12.
    Meinking TL, Elgart GW (2000) Scabies therapy for the millenium. Pediatr Dermatol17/2: 154–156CrossRefGoogle Scholar
  354. 13.
    Mellanby K (1953) Scabies. Oxford University Press, London, pp 1–81Google Scholar
  355. 14.
    Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  356. 15.
    Orkin M, Maibach HI (1993) Scabies therapy-1993. Semin Dermatol 12:22–25PubMedGoogle Scholar
  357. 16.
    Paasch U, Haustein U-F (2001) Behandlung der endemischen Skabies mit Allethrin, Permethrin und Ivermectin. Evaluation eines Behandlungskonzeptes. Hautarzt 52: 31–37PubMedCrossRefGoogle Scholar
  358. 17.
    Purvis RS, Tyring SK (1991) An outbreak of lindaneresistant scabies treated successfully with permethrin 5% cream. J Am Acad Dermato125: 1015–1016CrossRefGoogle Scholar
  359. 18.
    Roos TC, Alam M, Roos S, Merk HF, Bickers DR (2001) Pharmacotherapy of ectoparasitic infections. Drugs 61/8: 1067–1088CrossRefGoogle Scholar
  360. 19.
    Roth WI (1991) Scabies resistant to lindane 1 % lotion and crotamiton 10% cream. J Am Acad Dermatol 24: 502–503PubMedCrossRefGoogle Scholar
  361. 20.
    Schirren JM (1970) Die Scabies, eine epidemiologische Studie. Hautarzt 21: 170–176PubMedGoogle Scholar
  362. 21.
    Stein E (1974) Uncharakteristische dermatologische Krankheitsbilder durch Kortikosteroid-KombiantionsExterna. Ärztl Praxis 14: 613Google Scholar
  363. 22.
    Stüttgen G (1992) Skabies und Läuse heute. Dtsch Ärztebl17: AI–1534–AI–1546Google Scholar
  364. 23.
    Walker GJ, Johnstone PW (2000) Interventions for treating scabies. Cochrane Database Syst Rev 3: CD000320Google Scholar
  365. l.
    Braun-Fako O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  366. 2.
    Brown S, Becher I, Brady W (1995) Treatment of ectoparasitic infections: review of the English-Ianguage literature, 1982-1992. Clin Infect Dis 20 (Suppll): S104–109CrossRefGoogle Scholar
  367. 3.
    Brown TI, Yen-Moore A, Tyring SK (1999) An overview of sexually transmiited diseases. Part II. J Am Acad Dermatol41/5: 661–677CrossRefGoogle Scholar
  368. 4.
    Bums A (1987) The treatment ofPhthirus pubis infestation of the eyelashes. Br I Dermatol117: 741–743CrossRefGoogle Scholar
  369. 5.
    Kalter DC et al. (1987) Treatment of pediculosis pubis. Arch Dermatol 123: 1315–1319PubMedCrossRefGoogle Scholar
  370. 6.
    Opaneye AA, Iayaweera DT, Walzmann M, Wade AA (1993) Pediculosis pubis: a surrogate marker for sexualIy transmitted diseases. I R Soc Health 113/1: 6–7CrossRefGoogle Scholar
  371. 7.
    Scott GR (2001) European guideline for the management of pediculosis pubis. Int I STD AIDS (Suppl) 3/10: 62CrossRefGoogle Scholar
  372. 1.
    Berbis P (2001) Acitretine. Ann Dermatol Venereol 128/6-7: 737–745Google Scholar
  373. 2.
    Bobadilla J, Hulst RW van der, Kate FL ten, Tytgat GN (1999) Esophageal lichen planus. Gastrointest Endosc 50/2: 268–271CrossRefGoogle Scholar
  374. 3.
    Cribier B, Frances C, Chosidow O (1998) Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol134/12: 1521–1530CrossRefGoogle Scholar
  375. 4.
    Epstein JB, Truelove EL (1996) Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82/5: 532–536Google Scholar
  376. 5.
    Fundaro S, Spallanzani A, Ricchi E et al. (1998) Squamous-cell carcinoma developing within anal lichen planus: report of a case. Dis Colon Rectum 4111: 111–114CrossRefGoogle Scholar
  377. 6.
    Helm T et al. (1994) Lichen planus associated with neoplasia. A cell-mediated immune response to tumor antigens? J Am Acad Dermatol 30: 219–224PubMedCrossRefGoogle Scholar
  378. 7.
    Lener EV, Brieva J, Schachter M, West LE, West DP, elAzhary RA (2001) Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol137/4: 419–422Google Scholar
  379. 8.
    Maercke P van et al. (1988) Lichen ruber mucosae with esophageal involvement. Endoscopy 20: 158–160PubMedCrossRefGoogle Scholar
  380. 9.
    Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  381. 10.
    Payne CM, McPartiin JF, Hawley PR (1997) Ulcerative perianallichen planus. Br J Dermatol 136/3: 479CrossRefGoogle Scholar
  382. 11.
    Rußwurm R, Hagedorn M (1989) Lichen ruber ulcerosus. Hautarzt 40: 233–235PubMedGoogle Scholar
  383. 12.
    Shai A, Halevy S (1992) Lichen planus und Lichen planus-like eruptions. Pathogenesis and associated diseases. Int J Dermatol 31: 379–384PubMedCrossRefGoogle Scholar
  384. 13.
    Wörheide J et al. (1991) Plattenepithelkarzinom auf dem Boden eines Lichen ruber hypertrophicus an der Glans penis. Hautarzt 42: 112–115PubMedGoogle Scholar
  385. 14.
    Woo TY (1985) Systemic isotretinoin treatment of oral and cutaneous lichen planus. Cutis 35: 385–393PubMedGoogle Scholar
  386. 1.
    Barker LP, Gross P (1962) Lichen sclerosus et atrophicus of the female genitalia. A clinical study and diagnostic guide. Arch Dermatol 85: 362–373PubMedCrossRefGoogle Scholar
  387. 2.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin HeidelbergNew York TokyoCrossRefGoogle Scholar
  388. 3.
    Cruces MJ, De la Torre C, Losada A, Ocampo C, Garcia-Doval I (1998) Infantile pyramidal protrusion as a manifestation of lichen sclerosus et atrophicus. Arch Dermatol 134/9: 1118–1120CrossRefGoogle Scholar
  389. 4.
    Darier J (1892) Lichen plan sclereux. Ann Dermatol Syph 23: 833–837Google Scholar
  390. 5.
    Garzon MC, Paller AS (1999) Ultrapotent topical corticosteroid treatment of childhood genital lichen sclerosus. Arch Dermatol 135/5: 525–528CrossRefGoogle Scholar
  391. 6.
    Greve B, Hartschuh W, Raulin C (1999) Extragenitaler Lichen sclerosus et atrophicus-Behandlung durch gepulsten Farbstofflaser. Hautarzt 50: 805–808PubMedCrossRefGoogle Scholar
  392. 7.
    Hadlich J, Linse R (1983) Zur klinisch-histologischen Variationsbreite des Lichen sclerosus et atrophicus. Hautarzt 34: 453–455PubMedGoogle Scholar
  393. 8.
    Hagedorn M (1987) Lichen sclerosus et atrophicus: Behandlung mit Thym-Uvocal Creme. Aktuel Dermatol 13: 30–33Google Scholar
  394. 9.
    Hallopeau H (1887) Lelfons cliniques sur les maladees cutanées et syphiliques. Union Med Can 43: 472Google Scholar
  395. 10.
    Hofmann U, Megahed M (1994) Spinozelluläres Karzinom auf einem Lichen sclerosus et atrophicus der Vulva. Hautarzt 45: 104–107PubMedCrossRefGoogle Scholar
  396. 11.
    Kerscher M (1994) Treatment of localized scleroderma with PUVA-bath photochemotherapy. Lancet 343: 1233PubMedCrossRefGoogle Scholar
  397. 12.
    Kobyletzki G von, Freitag M, Hoffmann K, Altmeyer P, Kerscher M (1997) Balneophotochemotherapie mit 8-Methoxypsoralen bei Lichen sclerosus et atrophicus. Hautarzt 48/7: 488–491CrossRefGoogle Scholar
  398. 13.
    Kreuter A, Jansen T, Stucker M, Herde M, Hoffmann K, Altmeyer P, Kobyletzki G (2001) Low-dose ultravioletAl phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 26/1: 30–32CrossRefGoogle Scholar
  399. 14.
    Lipscombe TK, Wayte J, Wojnarowska F, Marren P, Luzzi G (1997) A study of clinical and aetiological factors and possible associations of lichen sclerosus in males. Australas J Dermatol 38/3: 132–136CrossRefGoogle Scholar
  400. 15.
    Meffert H, Davis BM, Grimwood RE (1995) Lichen sclerosus. J Am Acad Dermatol 32/3: 393–416CrossRefGoogle Scholar
  401. 16.
    Pampor M (1996) Therapie des Lichen sclerosus et atrophicus. Hautarzt 6: 429–430Google Scholar
  402. 17.
    Röcken M et al. (1995) Balneophototherapie. Hautarzt 46: 437–450PubMedCrossRefGoogle Scholar
  403. 18.
    Silverio A, Serri S (1975) Generalized bullous and haemorrhagic lichen sclerosus et atrophicus. Br J Dermatol 93: 215–217PubMedCrossRefGoogle Scholar
  404. 19.
    Skierlo P, Heise H (1987) Testosteronpropionat-Salbe-ein Therapieversuch beim Lichen sclerosus et atrophicus. Hautarzt 38: 295–297PubMedGoogle Scholar
  405. 20.
    Tritsch H (1968) Adenoides Plattenepithelcarcinom bei Lichen sclerosus et atrophicus. Arch Klin Exp Dermatol 232: 187–194PubMedGoogle Scholar
  406. 21.
    Warrington SA, San Lazaro C de (1996) Lichen sclerosus et atrophicus and sexual abuse. Arch Dis Child 75/6: 512–516CrossRefGoogle Scholar
  407. 22.
    Wier RF (1875) Ichtyosis of the tongue and vulva. NY State Y Med 246Google Scholar
  408. 1.
    Assmann K, Bonsmann G, Werner C, Metze D (2001) Acrodermatitis-enteropathica-ähnliche Hautveränderungen bei Ahornsirupkrankheit. Z Hautkr 76: 220–222Google Scholar
  409. 2.
    Brandt T (1936) Dermatitis in children with disturbances of the general condition and the absorption of food elements. Acta Derm Venerol (Stockh) 17: 513–546Google Scholar
  410. 3.
    Bryant TN (1981) Comparison of procedures for determination of cop per and zinc in serum by atomic absorptions spectroscopy. Clin Chim Acta 110: 83–90PubMedCrossRefGoogle Scholar
  411. 4.
    Danbolt N, Closs K (1942) Akrodermatitis enteropathica. Acta Derm Venerol (Stockh) 23: 127–169Google Scholar
  412. 5.
    Dupré A, Bonate JL, Carriere JP (1979) The hair in acrodermatitis enteropathica: A disease indicator? Acta Derm Venerol (Stockh) 59: 177–l78PubMedGoogle Scholar
  413. 6.
    Ferrandiz C et al.(1981) Acquired zinc deficiency syndrome during total parenteral alimentation. Dermatologica 163: 255–266PubMedCrossRefGoogle Scholar
  414. 7.
    Gschnait Th et al.(1982) Das exogen bedingte Zinkmangelsyndrom. Wien Klin Wochenschr 94: 475–479PubMedGoogle Scholar
  415. 8.
    Kaufmann J (1984) Acrodermatitis enteropathica bei totaler parenteraler Ernährung wegen Morbus Crohn. Z Hautkrankht 59: 1447–1453Google Scholar
  416. 9.
    Kay RG, Tasman-Jones C, Pydus J, Whiting R, Black H (1976) A syndrome of acute zinc deficiency during total parenteral alimentation in man. Ann Surg 183: 331–340PubMedCrossRefGoogle Scholar
  417. 10.
    Krasovec M, Frenk E (1996) Acrodermatitis enteropathica secondary to Crohn's disease. Dermatology 193/4: 361–363CrossRefGoogle Scholar
  418. 11.
    Löffler H, Effendy I (1999) Acrodermatitis-enteropathica-ähnliche Hautveränderungen durch parenterale Ernährung. Hautarzt 50: 499–502PubMedCrossRefGoogle Scholar
  419. 12.
    Moynahan EI, Barnes PM (1973) Zinc deficiency and a synthetic diet for lactose intolerance. Lancet 1: 676PubMedCrossRefGoogle Scholar
  420. 13.
    Moynahan EJ (1974) Acrodermatitis enteropathica. A lethal inherited human zincdeficiency disorder. Lancet II: 399CrossRefGoogle Scholar
  421. 14.
    Nürnberger F (1987) Zinkmangel bei künstlicher Ernährung. Z Hautkrankht 62: 104–110Google Scholar
  422. 15.
    Okada A, Takagi Y, Itakura T et al. (1976) Skin lesions during intravenous hyperalimentation: Zinc deficiency. Surgery 80: 629–635PubMedGoogle Scholar
  423. 16.
    Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York Tokyo, S 704–705CrossRefGoogle Scholar
  424. 17.
    Panizzon R (1995) Hautsymptome bei Störungen des Vitamin-und Mineralhaushalts. Ther Umsch 52/4: 257–263Google Scholar
  425. 18.
    Reich H, Opitz K, Bertram H-P, Fegeler K (1976) Lebensrettende Zinkbehandlung der Acrodermatitis enteropathica. Dtsch Med Wochenschr 101: 1724–1726PubMedCrossRefGoogle Scholar
  426. 19.
    Schwarz T, Rütter A (1996) Zink in der Dermatologie. TW Dermatologie 26: 372–377Google Scholar
  427. 21.
    Stein E (1982) Das Crohn-Syndrom. Z Allgemeinmed 31: 1702–1715Google Scholar
  428. 22.
    Vloten WA van, Bos LP (1978) Skin lesions in acquired zinc deficiency due to parenteral nutrition. Dermatologica 156: 175–183PubMedCrossRefGoogle Scholar
  429. 23.
    Wang K, Pugh EW, Griffen S et al. (2001) Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24.3. Am J Hum Genet 68/4: 1055–1060CrossRefGoogle Scholar
  430. 24.
    Weismann K, Hoyer H, Christensen E (1980) Acquired zinc deficiency in alcoholic liver cirrhosis: Report of two cases. Acta Derm Venerol (Stockh) 60: 447–449PubMedGoogle Scholar
  431. 25.
    Weismann K, Hoyer H (1982) Zinkmangeldermatosen. Der Hautarzt 33: 405–410Google Scholar
  432. 1.
    Alkemade JA, Tongeren JH van, Haelst UJ van, Smals A, Steijlen PM, Kerkhoff PC van de (1999) Delayed diagnosis of glueagonoma syndrome. Clin Exp Dermatol 24/6: 455–457CrossRefGoogle Scholar
  433. 2.
    Beeker SW et al. (1942) Cutaneous manifestations of internal malignant tumours. Areh Dermatol Syphilol 45: 1069–1080CrossRefGoogle Scholar
  434. 3.
    Chastain MA (2001) The glueagonoma syndrome: a review of its features and diseussion of new perspeetives. Am J Med Sei 321/5: 306–320Google Scholar
  435. 4.
    Darouty M el, Abu el Ela M (1996) Neerolytic migratory erythema without glueagonoma in patients with liver disease. J Am Aead Dermatol 34/6: 1092–1093CrossRefGoogle Scholar
  436. 5.
    Delaporte E, Catteau B, Piette F (1997) Neerolytic migratory erythema-like eruption in zine defieieney assoeiated with alcoholie liver disease. Br J Dermatol137/6: 1027–1028Google Scholar
  437. 6.
    Engelmann L et al. (1991) Erythema necrolyticum migrans-Glukogonom-Syndrom Aktuel Dermatol17:11–17Google Scholar
  438. 7.
    Kasper CS (1992) Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A ease report and literature review. Cutis 49/2: 120–122, 125-128Google Scholar
  439. 8.
    Konstantinow A, Balda BR, Starz H (1998) Erythema neerolyticum migrans nach Rektumkarzinom. Hautarzt 49/7: 591–595CrossRefGoogle Scholar
  440. 9.
    Mc Gavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME (1966) A glueagon-secreting alpha-cell eareinomaof the pancreas. N Engl J Med 274/25: 1408–1413CrossRefGoogle Scholar
  441. 10.
    Meyer J, Seidel B (1998) Dapson-Therapie des Erythema necroticans migrans bei „Pseudoglukagonom-Syndrom“ Akt Dermatol 24: 275–277Google Scholar
  442. 11.
    Nightingale KJ, Davies MG, Kingsnorth AN (1999) Glucagonoma syndrome: survival 24 years following diagnosis. Dig Surg 1611: 68–7 ai]12_Ossowski B, Baum C (1995) Das PseudoglukagonomSyndrom. Fallbericht, therapeutische Möglichkeiten und Hypothesen zur Ätiologie. Hautarzt 46/3: 173–176CrossRefGoogle Scholar
  443. 13.
    Pfau A et al. (1995) Das Glukogonom-Syndrom-Klinik und Therapie. Z Hautkrht 10: 725–728Google Scholar
  444. 14.
    Rappersberger K, Wolff-Schreiner E, Konrad K, Wolff K (1987) Das Glukogonom-Syndrom. Hautarzt 38: 589–598PubMedGoogle Scholar
  445. 15.
    Sinclair SA, Reynolds NJ (1997) Neerolytic migratory erythema and zinc defieiency. Br J Dermatol 136/5: 783–785CrossRefGoogle Scholar
  446. 16.
    Soga J, Yakuwa Y (1998) Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases. J Hepatobiliary Pancreat Surg 5/3. 312–319CrossRefGoogle Scholar
  447. 17.
    Strohm WD (1996) Paraneoplastische spastische Tetraparese bei Glukogonom-Syndrom. Erfolgreiche Therapie mit Octreotid, Dacarbacin und Interferon-a. Z Gastroenterol 34: 438–445PubMedGoogle Scholar
  448. 18.
    Sweet RD (1974) A dermatosis specifically associated with a tumor of pancreatic alpha cells. Br J Dermatol 90/3: 301–308CrossRefGoogle Scholar
  449. 19.
    Thorisdottir K, Camisa C, Tomecki KJ, Bergfeld WF (1994) Necrolytic migratory erythema: areport of three cases. J Am Acad Dermatol 30: 324–329PubMedCrossRefGoogle Scholar
  450. 20.
    Wermers RA, Fatourechi V, Kvols LK (1996) Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors. Mayo Clin Proc 71/11: 1030–1038CrossRefGoogle Scholar
  451. 21.
    Wilkinson DS (1971) Necrolytic migratory erythema with pancreatic carcinoma. Proc R Soc Med 64: 1197–1198PubMedGoogle Scholar
  452. 1.
    Andreev VC, Boyanov L, Tsankov N (1981) Generalized acanthosis nigricans. Dermatologica 163: 19–24PubMedCrossRefGoogle Scholar
  453. 2.
    Böhm M, Luger A, Metze D (1999) Urthelkarzinom-assoziierte Acanthosis nigricans-symptomatische Therapie mit Cakipotriol. Hautarzt 50: 593–596PubMedCrossRefGoogle Scholar
  454. 3.
    Bonnekoh B, Thiele B, Merk H, Mahrle G (1989) Systemische Photo chemotherapie (PUVA) bei Acanthosis nigricans maligna: Regression von Keratose, Hyperpigmentierung und Pruritus. Z Hautkrankht 64: 1059–1062Google Scholar
  455. 4.
    Braun-Fako O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  456. 5.
    Curth-Ollendorff H (1979) Malignant Acanthosis nigricans. In: Fitzpatrick TB et al. (ed) Dermatology in general medicine,2 nd edn. McGraw-Hill, New York, 1346 ffGoogle Scholar
  457. 6.
    Darmstadt GL, Yokel BK, Horn TD (1991) Treatment of acanthosis nigricans with tretinoin. Arch Dermatol 127: 1139–1140PubMedCrossRefGoogle Scholar
  458. 7.
    EImer KB, George RM (2001) HAIR-AN syndrome: a multisystem challenge. Am Farn Physician 63/12: 2385–2390Google Scholar
  459. 8.
    Janovsky V (1890) Acanthosis nigricans. Internat. Atlas seltener Hautkrankheiten, Bd 11Google Scholar
  460. 9.
    Larregue M et al.(1979) Pachydermatoglyphie. Signe en faveur de la malignite au cours de l'acanthosis nigricans. Ann Dermatol Venereol (Paris) 106:781–785PubMedGoogle Scholar
  461. 10.
    Marghescu S, Wolff H, Braun-Fako O (1982) Kongenitale Erythrokeratodermie mit Taubheit Schnyder. Hautarzt 33: 416–419PubMedGoogle Scholar
  462. 11.
    Matsuoka LY, Wortsman J, Goldman J (1993) Acanthosis nigricans. Clin Dermatol 11: 21–25PubMedCrossRefGoogle Scholar
  463. 12.
    Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  464. 13.
    Pollitzer S (1890) Acanthosis nigricans. Internat. Atlas seltener Hautkrankheiten, Bd 10Google Scholar
  465. 14.
    Requena L, Aguilar A, Renedo G, Martin L, Pique E, Farina MC, Escalonilla P (1995) Tripe palms: a cutaneous marker of internal malignancy. J Dermatol 22/7:492–495Google Scholar
  466. 15.
    Schönlein K-M, Worret W-J (1994) Paraneoplastische Syndrome der Haut. hautnah 3: 301–310Google Scholar
  467. 16.
    Schnyder UW (1971) Vorwort. In: Herzberg JJ (Hrsg) Kutane paraneoplastische Syndrome. Gustav Fischer Verlag, StuttgartGoogle Scholar
  468. 17.
    Schwartz RA (1981) Acanthosis nigricans, florid cutaneous papillomatosis and the sign of Leser-Trelat. Cutis 28: 319–334PubMedGoogle Scholar
  469. 18.
    Schwartz RA (1994) Acanthosis nigricans. J Am Acad Dermatol31: 1–19PubMedCrossRefGoogle Scholar
  470. 19.
    Stieler W, Plewig G (1987) Acanthosis nigricans maligna und Leser-Trelat-Zeichen bei Doppelmalignom von Mamma und Magen. Z Hautkrankht 62/5: 344–366Google Scholar
  471. 20.
    Weishaar E, Bonnekoh B, Franke I, Gollnick H (2001) Erfolgreiche symptomatische Tarazotentherapie der juvenilen Acanthosis nigricans vom familiär adipositasassoziierten Typ bei Insulinresistenz. Hautarzt 52: 499–503CrossRefGoogle Scholar
  472. 21.
    Wolff H (2001) Kutane Paraneoplasien. Hautarzt 52: 159–172PubMedCrossRefGoogle Scholar
  473. 22.
    Yeh JS, Munn SE, Plunkett TA, Harper PG, Hopster DJ, Vivier WA du (2000) Coexistence of acanthosis nigricans and the sign of Leser-Trelat in a patient with gastric adenocarcinoma: a case report and literature review. J Am Acad Dermatol42: 357–362PubMedCrossRefGoogle Scholar
  474. 1.
    Bell HK, Farrar CW, Curley RK (2001) Papu1ar acantho1ytic dyskeratosis of the vulva. Clin Exp Dermatol 26/5: 386–388CrossRefGoogle Scholar
  475. 2.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  476. 3.
    Böhm I (1996) Dyskeratosis follicularis Darier (ICD Q 28.8). Therapeutische Trends und Leitlinien. Dtsch Dermatologe 44: 794Google Scholar
  477. 4.
    Burge S (1994) Darier's disease-the clinical features and pathogenesis. Clin Exp Dermatoll9/3: 193–205CrossRefGoogle Scholar
  478. 5.
    Burge S (1999) Management of Darier's disease. Clin Exp Dermatol 24/2: 53–56CrossRefGoogle Scholar
  479. 6.
    Leverkus M, Rose C, Bröcker EB, Hamm H (1999) Intertriginöse akantholytische Dyskeratose. Abortive Form eines Morbus Darier oder eigene klinische Entität? Hautarzt 50/10: 733–738CrossRefGoogle Scholar
  480. 7.
    Mailänder W, Stieler W, Stadler R (1991) Ausgedehnte Kopfhautbeteiligung bei Morbus Darier. Aktuel Dermatol17: 284–286Google Scholar
  481. 8.
    McMillan JR, Shimizu H (2001) Desmosomes: structure and function in normal and diseased epidermis. J Dermatol28/6: 291–298Google Scholar
  482. 9.
    Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  483. 10.
    Sakuntabhai A, Ruiz-Perez V, Carter S et al. (1999) Mutations in ATP2A2, encoding a Ca2 + pump, cause Darier disease. Nat Genet 21/3: 271–277Google Scholar
  484. 11.
    Schuhmachers G, Vogt HJ (1992) Familiäre Dyskeratosis follicularis. Dtsch Dermatologe 1: 53–60Google Scholar
  485. 1.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie. 4. Aufl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  486. 2.
    Burge SM, Millard PR, Wojnarowska F (1991) HaileyHailey disease: a widespread abnormality of ceH adhesion. Br J Dermatol 124/4: 329–332CrossRefGoogle Scholar
  487. 3.
    Burge SM (1992) Hailey-Hailey disease: the clinical features, response to treatment and prognosis. Br J Dermatol 126: 275–282PubMedCrossRefGoogle Scholar
  488. 4.
    Christian MM, Moy RL (1999) Treatment of HaileyHailey disease (or benign familial pemphigus) using short pulsed and short dweH time carbon dioxide lasers. Dermatol Surg 25/8: 661–663CrossRefGoogle Scholar
  489. 5.
    Ganter G (1998) Lokale Kortikosteroidtherapie des Pemphigus chronicus benignus familiaris (PCBF) M.Hailey-Hailey. Akt Dermatol24: 271–274Google Scholar
  490. 6.
    Gschnait Fr (1973) Pemphigus familiaris chronicus benignus (Hailey-Hailey). Hautarzt 24: 243–247PubMedGoogle Scholar
  491. 7.
    Hailey H, Hailey H (1939) Familial benign chronic pemphigus. Arch Dermatol Syph (Chic) 39: 679–685Google Scholar
  492. 8.
    Hamm H, Metze D, Bröcker EB (1994) Hailey-Hailey disease. Eradication by dermabrasion. Arch Dermatol 130: 1143–1149PubMedCrossRefGoogle Scholar
  493. 9.
    Ikeda S et al. (1993) Successful management of HaileyHailey disease with potent topical steroid ointment. J Dermatol Sei 5: 205–211CrossRefGoogle Scholar
  494. 10.
    Kirtschig G, Gieler U, Happle R (1993) Treatment of Hailey-Hailey disease by dermabrasion. J Am Acad Dermatol 30: 784–786CrossRefGoogle Scholar
  495. 11.
    Korge BP et al. (1995) Morbus Hailey-Hailey: Topische Behandlung mit Calcipotriol. Z Hautkrankht 12: 910–912Google Scholar
  496. 12.
    Langenberg A, Berger TG, Cardelli M, Rodman OG, Estes S, Barron DR (1992) Genital benign chronic pemphigus (Hailey-Hailey disease) presenting as condylomas. J Am Acad Dermato126/6: 951–955CrossRefGoogle Scholar
  497. l3.
    Menz P, Jackson IT, Connolly S (1987) Surgical control of Hailey-Hailey disease. Br J Plast Surg 40/6: 557–561CrossRefGoogle Scholar
  498. 14.
    Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  499. 15.
    Richard G, Linse R, Harth W (1993) Morbus HaileyHailey. Früherfassung von Merkmalsträgern durch einen UV-Provokationstest-klinische Relevanz der Methode. Hautarzt 44: 376–379PubMedGoogle Scholar
  500. 16.
    Schirren H, Schirren CG, Schlupen EM, Volkenandt M, Kind P (1995) Exazerbation eines Morbus Hailey-Hailey durch Infektion mit Herpes-simplex-Virus. Hautarzt 46/7: 494–497CrossRefGoogle Scholar
  501. 17.
    Sudbrak R, Brown J, Dobson-Stone C et al. (2000) Hailey-Hailey disease is caused by mutations inATP2Cl encoding a novel Ca(2 +) pump. Hum Mol Genet 9/: 1131–1140CrossRefGoogle Scholar
  502. 18.
    Teikemeier G, Stein E (1996) Kontrollierte Dermabrasion mit einem neuartigen Erbium-YAG-Lasersystem. Hautarzt 47: 530–532PubMedCrossRefGoogle Scholar
  503. 1.
    Anzai S, Takeo N, Yamaguchi T et al. (1999) Squamous cell carcinoma in a renal transplant recipient with linear porokeratosis. J Dermatol 26/4: 244–247Google Scholar
  504. 2.
    Bacharach-Buhles M et al. (1990) Porokeratosis Mibelli gigantea. Hautarzt 41: 633–635PubMedGoogle Scholar
  505. 3.
    Cort DF, Abdel-Aziz AM (1972) Epithelioma arising in porokeratosis of Mibelli. Br J Plast Surg 25: 318–328PubMedCrossRefGoogle Scholar
  506. 4.
    Coskey RJ, Mehregan A (1975) Bowen disease associated with porokeratosis of Mibelli. Arch Dermatol 111: 1480–1481PubMedCrossRefGoogle Scholar
  507. 5.
    Ehlers G, Rothe A (1971) Porokeratosis Mibelli mit multiplen Praecancerosen und Plattenepithelcarcinomen. Hautarzt 22: 68–73PubMedGoogle Scholar
  508. 6.
    Götz A, Kopera D, Wach F et al. (1999) Porokeratosis Mibelli gigantea. Fallbericht und Literaturübersicht. Hautarzt 50: 435–438PubMedCrossRefGoogle Scholar
  509. 7.
    Hsu WT et al. (1992) Cutaneous T-celllymphoma with porokeratosis-like lesious. J Am Acad Dermatol 27: 327–330PubMedCrossRefGoogle Scholar
  510. 8.
    Kanitakis J, Euvrard S, Faure M, Claudy A (1998) Porokeratosis and immunosuppression. Eur J Dermatol8/7: 459–465Google Scholar
  511. 9.
    Koch P et al. (1995) Disseminierte superfizielle Porokeratose, ortikosteroidtherapie und Immunsuppression. Hautkrankht 11: 822–826Google Scholar
  512. 10.
    Lucker GPH et al.(1995) An unusual case of porokeratosis involving the natal cleft: porokeratosis ptychotropica? Br J Dermatol132: 150–151PubMedCrossRefGoogle Scholar
  513. 11.
    Merkle T et al. (1992) Reticulate porokeratosis: Successful treatment with COz-Laser vaporization. Clin Exp Dermatol17: 178–181PubMedCrossRefGoogle Scholar
  514. 12.
    Mibelli V (1893) Contribution allo studio della ipercheratosi dei canali sudoriferi. G Ital Mal Venerol 28: 313–355Google Scholar
  515. 13.
    Mikhail GR, Wertheimer GW (1968) Clinical variants of porokeratosis (Mibelli). Arch Dermatol 98: 124–131PubMedCrossRefGoogle Scholar
  516. 14.
    Morton CA et al. (1995) Porokeratosis and Crohn's disease. J Am Acad Dermatol 32: 894–897PubMedCrossRefGoogle Scholar
  517. 15.
    Oberste-Lehn H, Moll B (1968) Porokeratosis Mibelli und Stachelzellcarcinom. Hautarzt 19: 399–403PubMedGoogle Scholar
  518. 16.
    Otsuka F et al. (1991) Porokeratosis and malignant skin tumors. J Cancer Res Clin Oncol117: 55–60PubMedCrossRefGoogle Scholar
  519. 17.
    Rabbin PE, Baldwin HE (1993) Treatment ofporokeratosis of Mibelli with COz-Iaser vaporization versus surgical excision with splitthickness skin graft. A comparison. J Dermatol Surg Oncol 19: 199–202PubMedGoogle Scholar
  520. 18.
    Respighi E (1893) Di unna ipercheratosi non ancora discritta. G Hal Mal Venerol 28: 356–386Google Scholar
  521. 19.
    Rodriguez EA, Jakubowicz S, Chinchilla DA, Carril A, Viglioglia PA (1996) Porokeratosis of Mibelli and HIV-Infection. Int J Dermatol 35/6: 402–404CrossRefGoogle Scholar
  522. 20.
    Sasson M, Krain AD (1996) Porokeratosis and cutaneous malignancy. A review. Dermatol Surg 22/4: 339–342CrossRefGoogle Scholar
  523. 21.
    Schamroth JM, Zlotogorski A, Gilead L (1997) Porokeratosis of Mibelli. Overview and review of the literature. Acta Derm Venereol 77/3: 207–213Google Scholar
  524. 22.
    Schmiedeberg S von et al. (1995) Das Spektrum der Porokeratosis Mibelli. Z Hautkrankht 4: 289–292Google Scholar
  525. 23.
    Stone N, Ratnavel R, Wilkinson JD (1999) Bilateral perianal inflammatory verrucous porokeratosis (Porokeratosis ptychtropica). Br J Dermatol140/3: 553–555CrossRefGoogle Scholar
  526. 24.
    Torras H et al. (1981) Porokeratosis Mibelli gigantea. Ann Dermatol Venerol108: 477–478Google Scholar
  527. 25.
    Webster GF (2001) Are porokeratoses an infection? Arch Dermatol137/5: 665Google Scholar
  528. 26.
    Wurth PB, Klaus MV (1992) Porokeratosis of Mibelli following heart transplant. Int J Dermatol31: 52–54CrossRefGoogle Scholar
  529. 27.
    Zenarola P et al. (1993) Exacerbation of porokeratosis: a sign of immunodepression. J Am Acad Dermatol 29: 1035–1036PubMedCrossRefGoogle Scholar
  530. 1.
    Andreßen C, Henseler T (1982) Erblichkeit der Psoriasis. Hautarzt 33: 214PubMedGoogle Scholar
  531. 2.
    Böhringer D, Stein E (1978) Saalmannlampen-Bestrahlung der Psoriasis-Ein bedeutender Fortschritt im Urteil der Patienten. Dtsch Dermatologe 26: 2l–26Google Scholar
  532. 3.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Autl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  533. 4.
    Costello P, FitzGerald O (2001) Disease mechanisms in psoriasis and psoriatic arthritis. Curr Rheumatol Rep 3/5: 419–427CrossRefGoogle Scholar
  534. 5.
    Disch R (1995) Klinik und Therapie der Psoriasis. TW Dermatologie KOMPAKT, 4–8Google Scholar
  535. 6.
    Farber EM, Nall L (1992) Perianal and intergluteal psoriasis. Cutis 50/5: 336–338Google Scholar
  536. 7.
    Herbst RA, Hoch O, Kapp A, Weiss J (2000) Guttate psoriasis triggered by perianal streptococcal dermatitis in a four-year-old boy. J Am Acad Dermatol 42/5: 885–887CrossRefGoogle Scholar
  537. 8.
    Highton A, Quell J (1995) Calcipotriene ointment 0,005 % for psoriasis: a safety and efficacy study. J Am Acad Dermatol 32: 67–72PubMedCrossRefGoogle Scholar
  538. 9.
    Kerscher M et al. (1993) Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB. Lancet 342:923PubMedCrossRefGoogle Scholar
  539. 10.
    Kienbaum S et al. (1995) Intertriginöse Psoriasis: Therapie mit Calcipotriol. Z Hautkrankht 10: 764–766Google Scholar
  540. 11.
    Kirby B, Griffiths CE (2001) Psoriasis: the future. Br J Dermatol144 (Suppl 58): 37–43PubMedGoogle Scholar
  541. 12.
    Lebwohl M, Ali S (2001) Treatment of Psoriasis. Part 2: Topical therapy and phototherapy. J Am Acad Dermatol. 45/4: 487–498CrossRefGoogle Scholar
  542. 13.
    Lebwohl M, Ali S (2001) Treatment of psoriasis. Part 2: Systemic therapies. J Am Acad Dermatol 45/4: 649–661CrossRefGoogle Scholar
  543. 14.
    Lehmann P, Ruzicka T (1996) Neue Entwicklungen in der Psoriasistherapie. Dtsch Arztbl48: A–3188–A–3193Google Scholar
  544. 15.
    Lomholt G (1963) Psoriasis. GEC. GAD CopenhagenGoogle Scholar
  545. 16.
    Mauss J (1978) Die perianale Psoriasis-ein verlässlicher Befund bei der Differentialdiagnose der Schuppenflechte. Z Hautkr 53/9: 303–304Google Scholar
  546. 17.
    Meisel CW (1996) Topische Therapie der leichten bis mittelschweren Psoriasis vulgaris. Dtsch Dermatologe 44: 1132–1135Google Scholar
  547. 18.
    Michalowski R (1983) Erythrokeratodermia periorificialis mit Akrenbeteiligung. Der Hautarzt34:465–467Google Scholar
  548. 19.
    Schaller J, Metz K, Schmidt U, Kunze J (1996) Kutane Malakoplakie bei einem Patienten mit Psoriasis vulgaris. Hautarzt 47/10: 763–766CrossRefGoogle Scholar
  549. 20.
    Stein E (1977) Selektiertes UV-Licht gegen Psoriasis-Fortschritt durch Verzicht auf den Photosensibilisator. Ärztl Praxis 63: 2741–2742Google Scholar
  550. 21.
    Stein E, Böhringer D (1979) UV-Bestrahlungsgeräte. Arzt Wirtschaft 20: 31–40Google Scholar
  551. 22.
    Steinmeyer K, Grundmann-Kollmann M, Podda M, Kaufmann R (2001) Creme-PUVA-Photochemotherapie bei chronisch stationärer Psoriasis vulgaris. Hautarzt 52: 885–887PubMedCrossRefGoogle Scholar
  552. 1.
    Bastiaens MT, Zwan NV, Verschueren GL, Stoof TJ, Nieboer C (1994) Three cases of pemphigus vegetans: induction by enalapril-association with internal malignancy. Int J Dermatol33/3: 168–171Google Scholar
  553. 2.
    Civatte A (1943) III. Structure histologique de la bulle des pemphigus vrais. Ann Derm Syph (Paris) 8/3: 16Google Scholar
  554. 3.
    Gerharz M, Stadler R (1987) Pemphigus vegetans vom Typ Hallopeau. Hautarzt 38: 371–374PubMedGoogle Scholar
  555. 4.
    Guerra-Rodrigo F, Cardoso JPM (1971) Pemphigus vegetans: Immunfluorescent and ultrastructural studies in a patient. Arch Dermatol 104: 412–419PubMedCrossRefGoogle Scholar
  556. 5.
    Heaphy MR, Tucker SB, Winkelmann RK (1976) Benign papular acantholytic dermatosis. Arch Dermatol 112:814PubMedCrossRefGoogle Scholar
  557. 6.
    Jansen T, Messer G, Meurer M, Plewig G (2001) Pemphigus vegetans. Eine historische Betrachtung. Hautarzt 52:504–509PubMedCrossRefGoogle Scholar
  558. 7.
    Lateef A, Packles MR, White SM, Don PC, Weinberg JM (1999) Pemphigus vegetans in association with human immunodeficiency virus. Int J Dermatol 38/10: 778–781CrossRefGoogle Scholar
  559. 8.
    Schmidt E, Bröcker E-B, Zillikens D (2000) Pemphigus. Verlust des desmosomalen Zell-Zell-Kontaktes. Hautarzt 51: 309–318PubMedCrossRefGoogle Scholar
  560. 9.
    Wong KT, Wong KK (1994) A case of acantholytic dermatosis of the vulva with features of pemphigus vegetans. J Cutan Pathol2115:453–456CrossRefGoogle Scholar
  561. 1.
    Bang D, Lee JH, Lee ES et al. (2001) Epidemiologie and clinical survey of Behçet's disease in Korea: the first multicenter-study. J Korean Med Sci 16/5: 615–618Google Scholar
  562. 2.
    Behçet H (1937) Über rezidivierende, aphthöse, durch einen Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105: 1152–1157Google Scholar
  563. 3.
    Bousvaros A, Mueller B (2001) Thalidomide in gastrointestinal disorders. Drugs 61/6: 777–787CrossRefGoogle Scholar
  564. 4.
    Bratzke B, Zouboulis ChC, Kurz K, Wyrobisch W, Hoffmann F, Orfanos CE (1990) Therapie des Adamantiades-Behçet-Syndroms. Zentralbl Haut 157: 960–961Google Scholar
  565. 5.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Autl. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  566. 6.
    Christoph R (1993) Morbus Behçet: wie abgrenzen gegen M. Crohn? Ärztl Praxis 96:10Google Scholar
  567. 7.
    Diaz-Llopis M, Cervera M, Menezo JL (1990) Cyclosporin treatment of Behçet's disease: a long-term study. Curr Eye Res 9 [Suppl]: 17–23PubMedCrossRefGoogle Scholar
  568. 8.
    Djawari D (1981) Benigne orale Aphthosis und Morbus Behçet-Epidemiologie und genetische Aspekte. Der Hautarzt (Suppl V) 32:298–301Google Scholar
  569. 9.
    Ehrlich GE (1999) Behçet's disease: an update. ComprTher 25/4: 216–220Google Scholar
  570. 10.
    Empey DW (1972) Rectal and colonic ulceration in Behçet's disease. Br J Surg 59: 173–178PubMedCrossRefGoogle Scholar
  571. 11.
    Ferguson MM, Wray D, Carmichael HA, Russell RI, Lee FD (1980) Coeliac disease assoeiated with recurrent aphthae. Gut 21: 223–22PubMedCrossRefGoogle Scholar
  572. 12.
    Fierlbeck G, Rassner G (1990) Morbus Behçet: Therapie mit rekombinantem Interferon gamma. Aktuel Dermatol 16: 226–230Google Scholar
  573. 13.
    Fierlbeck G, Rassner G (1991) Interferon gamma als Langzeittherapeutikum bei Morbus Behçet. Dermatologie 5:14Google Scholar
  574. 14.
    Hamuryudan V, Yurdakul S, Rosenkaimer F, Yaziei H (1991) Inefficacy of topical alpha interferon in the treatment of oral ulcers of Behçet's syndrome: a randomized, double blind trial. Br J Rheumatol 30: 395–396PubMedCrossRefGoogle Scholar
  575. 15.
    Hornstein OP (1981) Orale Aphthosen und Morbus Behçet-Historische Vorbemerkungen und neue nosologische Konzepte. Hautarzt (Suppl V) 32: 297–298Google Scholar
  576. 16.
    International Study Group for Behçet's disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335: 1078–1080Google Scholar
  577. 17.
    Jorizzo JL, White WL, Wise CM et al. (1991) Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteriitis nodosa and Behçet's disease. J Am Acad Dermatol 24: 973–978PubMedCrossRefGoogle Scholar
  578. 18.
    Jung RT, Chalmin TM, Joysey VC (1978) HLA in Behçet's disease. Lancet 2: 694Google Scholar
  579. 19.
    Kaklamani VG, Kaklamanis PG (2001) Treatment of Behçet's disease-an update. Semin Arthritis Rheum 30/5: 299–312CrossRefGoogle Scholar
  580. 20.
    Kurtz MD (1976) Colonoscopie diagnosis of nonspecific ulcer of the colon. Gastrointest Endosc 23: 90PubMedCrossRefGoogle Scholar
  581. 21.
    Larson H (1990) Treatment of severe colitis in Behlfet's syndrome with thalidomide. J Intern Med 228:405–407CrossRefGoogle Scholar
  582. 22.
    Lebwohl O, Forde KA, Berdon WE (1977) Ulcerative esophagitis and colitis in a pediatrie patient with Behlfet's syndrome. Am J Gastroenterol 68: 550–554PubMedGoogle Scholar
  583. 23.
    Lehner T, Barnes CG (1980) Behlfet's syndrome: Clinical and immunologieal features. Academie Press, New YorkGoogle Scholar
  584. 24.
    Moraes M, Russo G (2001) Thalidomide and its dermatologie uses. Am J Med Sci 321/5: 321–326CrossRefGoogle Scholar
  585. 25.
    Nussenblatt RB, Palestine AG, Rook AH, Scher I, Wacker WB, Gery I (1983) Treatment of intraocular inflammatory disease with cyclosporin A. Lancet 2/8344: 235–238CrossRefGoogle Scholar
  586. 26.
    Onder M, Gurer MA (2000) The multiple faces of Behlfet's disease and its aetiologieal factors. J Eur Acad Dermatol Venereol1512: 126–136Google Scholar
  587. 27.
    Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  588. 28.
    Shimizu T, Ogino T (1975) Clinieo-pathological studies on the intestinaliesions in Behlfet's disease-with special reference to entero-Behlfet's syndrome. Stomach Intestine 10: 1593–1598Google Scholar
  589. 29.
    Simsek H, Dundar S, Telatar H (1991) Treatment of Behlfet's disease with indomethacin. Int J Dermatol 30: 54–57PubMedCrossRefGoogle Scholar
  590. 30.
    Sloper CM, Powell RJ, Dua HS (1999) Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophtalmology 106/4: 723–728CrossRefGoogle Scholar
  591. 31.
    Sobel JD, Haim S, Shafrir A, Gellei B (1973) Cutaneous hyperreactivity in Behlfet's disease. Dermatologiea 146:350–356CrossRefGoogle Scholar
  592. 32.
    Stadler R et al. (1987) Morbus Behlfet und exogenes Interferon. Hautarzt 38: 97–100PubMedGoogle Scholar
  593. 33.
    Sullu Y, Oge I, Erkan D, Ariturk N, Mohajeri F (1998) Cyclosporin-A therapy in severe uveitis of Behlfet's disease. Acta Ophtalmol 76/1: 96–99CrossRefGoogle Scholar
  594. 34.
    Takeuschi A, Hashimoto T (1988) Oral prostagiandin EI as a therapeutie modality for leg ulcers in Behlfet's disease. Int J Clin Pharmacol Res 7:283–289Google Scholar
  595. 35.
    Torök L, Egyedi K (1983) Behandlung von Morbus Behlfet mit Kolchizin. Hautarzt 34: 87–88PubMedGoogle Scholar
  596. 36.
    Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL (2001) Treatment of intestinal Behlfet's syndrome with chimeric tumour necrosis factor alpha antibody. Gut 49/5: 725–728CrossRefGoogle Scholar
  597. 37.
    Tüzün Y, Yazici M, Pazarli H, Yalcin B, Yurdakul S, Müftüoglu A (1979) The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Behlfet's disease in Turkey. Acta Dermatovener (Stockh) 59: 77–79Google Scholar
  598. 38.
    Weimann C, Keitel R, Keitel W, Zimmermann Ch (1991) Das Behlfet-Syndrom. Mögliehe Differenzialdiagnose bei multisystemischer Symptomatik. Z Gesamte Inn Med 46:234–236PubMedGoogle Scholar
  599. 39.
    Zouboulis CC, Büttner P, Djawari D et al. (1993) HLAMuster bei Morbus Adamantiades-Behlfet in Deutschland: Assoziation zum Auftreten, der klinischen Symptomatik und dem Krankheitsverlauf bei 39 Patienten. Hautarzt 44: 81–85PubMedGoogle Scholar
  600. 40.
    Zouboulis CC, Treudler R, Orfanos CE (1993) Morbus Admantiades-Behlfet: therapeutischer Einsatz von systemischen rekombinantem Interferon-alpha-2 a. Hautarzt 44: 440–445PubMedGoogle Scholar
  601. 41.
    Zouboulis CC, Kotter I, Djawari D et al. (1997) Epidemiologieal features of Adamantiades-Behlfet's disease in Germany and in Europe. Yonsei Med J 38/6: 411–422Google Scholar
  602. 1.
    Achtelik W, Wolff HH (1991) Schweißdrüsentumoren und Morbus Paget: immunhistologische Marker zur Differenzierung und Differentialdiagnose. Pathologie 12: 316–321Google Scholar
  603. 2.
    Arensmeier M et al. (1994) Topische Therapie des extramammären Morbus Paget. Hautarzt 45: 780–782PubMedCrossRefGoogle Scholar
  604. 3.
    Arminski TC, Pollard RJ (1973) Paget's disease of the anus secundary to a malignant papillary adenoma of the rectum. Dis Colon Rectum 16: 46PubMedCrossRefGoogle Scholar
  605. 4.
    Blasco T, Garcia-Armengol J, Roig JV, Garcia-Castel J (1998) Perianal Paget's disease. Coloproctology 20: 7–10CrossRefGoogle Scholar
  606. 5.
    Dörner A, Müller S, Dietel M (1987) Der perianale (extramammäre) Morbus Paget. Coloproctology 6: 327–330Google Scholar
  607. 6.
    Fligiel Z, Kaneko M (1975) Extramammary Paget's disease of the extern al ear canal in association with ceruminous gland carcinoma: a case report. Cancer 36: 1072PubMedCrossRefGoogle Scholar
  608. 7.
    Furukawa F, Kashihara M, Miyauchi H, Yamabe H, Hamashimo Y, Imamura S (1984) Evaluation of carcinoembryonie antigen in extramammary Paget's disease. J Cutan Pathol 11: 558–561PubMedCrossRefGoogle Scholar
  609. 8.
    Goldblum JR, Hart WR (1998) Perianal Paget's disease: a histologie and immunohistochemieal study of 11 cases with and without associated rectal adenocarcinoma. Am J Surg Pathol 22/2: 170–179CrossRefGoogle Scholar
  610. 9.
    Goldmann S, Ihre T, Lagerstedt U, Svensson C (1992) Perianal Paget's disease: report of five cases. Int J Colorectal Dis 7/3: 167–169CrossRefGoogle Scholar
  611. 10.
    Gunn A, Fox H (1971) Perianal Paget's disease. Br J Dermatol 85: 476PubMedCrossRefGoogle Scholar
  612. 11.
    Heitland W (1997) Anale und perianale Tumoren. Ther Umsch 54/4: 202–204Google Scholar
  613. 12.
    Herzog U, Flue M von, Roche R de, Curschellas E (1993) Perianal extramammary Paget's disease. Report of two cases. Eur J Surg OncoI19/5: 469–473Google Scholar
  614. 13.
    Jabbar AS (2000) Perianal extramammary Paget's disease. Eur J Surg Oncol 26/6: 612–614CrossRefGoogle Scholar
  615. 14.
    Krahl D (1994) Östrogenrezeptor-assoziiertes Protein (p 29) und Histogenese des extramammären Morbus Paget. Z Hautkrankht 11: 764–768Google Scholar
  616. 15.
    Kubota K, Akasu T, Nakanishi Y, Sugihara K, Fujita S, Moriya Y (1998) Perianal Paget's disease associated with rectal carcinoma: a case report. Jpn J Clin Oncol 28/5: 347–350CrossRefGoogle Scholar
  617. 16.
    Lam DT, Batista O, Weiss EG, Nogueras JJ, Wexner SD (2001) Staged excision and split-thickness skin graft for circumferential perianal Paget's disease. Dis Colon Rectum 44/6: 868–870CrossRefGoogle Scholar
  618. 17.
    Landthaler M (1988) Extramammärer Paget: Wie kann ich helfen? Ärztl Praxis 7: 1O9Google Scholar
  619. 18.
    Lechner Wet al. (1987) Extramammärer Morbus Paget. Aktuel Dermatol 13: 43–46Google Scholar
  620. 19.
    Moll I, Moll R (1985) Cells of extramammary Paget's disease express cytokeratins different from those of epidermal cells. J Invest Dermatol 84: 3–8PubMedCrossRefGoogle Scholar
  621. 20.
    Neumann R (1986) Extramammärer Morbus Paget-assoziiert mit einem Magenkarzinom. Hautarzt 37: 568–570PubMedGoogle Scholar
  622. 21.
    Oji M, Furue M, Tamaki K (1984) Serum carcinoembryonie antigen level in Paget's disease. Br J Dermatol 110: 211–213PubMedCrossRefGoogle Scholar
  623. 22.
    Orfanos CE, Garbe C (1995) Therapie der Hautkrankheiten. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  624. 23.
    Paget J (1874) One disease of the mammary areola proceeding cancer of the mammary gland. St Bart Hosp Rep 10: 87Google Scholar
  625. 24.
    Parmley Th, Woodruff JD, Julian CG (1975) Invasive vulvar Paget's disease. Obstet Gynecol46: 341PubMedGoogle Scholar
  626. 25.
    Parturier-Albot M, Prevost AG, Albot G, Boigert M (1982) Les carcinomes multieentriques de la region ano-rectale. Apropos de l'association d'un epithelioma villeux de l'ampoule rectale, d'une maladie de Bowen anale et d'une maladie de Paget anale. Ann Gastroenterol Hépatol 18: 227–235Google Scholar
  627. 26.
    Remond B et al. (1993) Umbilical Paget's disease and prostatie carcinoma. Br J Dermatol 128: 448–450PubMedCrossRefGoogle Scholar
  628. 27.
    Runfola MA, Weber TK, Rodriguez-Bigas MA, Dougherty TJ, Petrelli NJ (2000) Photodynamie therapy for residual neoplasms of the perianal skin. Dis Colon Rectum 43/4: 499–502CrossRefGoogle Scholar
  629. 28.
    Sarmiento JM, Wolff BG, Burgart LJ, Frizelle FA, Ilstrup DM (1997) Paget's disease of the perianal region-an aggressive disease? Dis Colon Rectum 40/10: 1187–1194CrossRefGoogle Scholar
  630. 29.
    Tjandra J (1988) Perianal Paget's disease: report of three cases. Dis Colon Rectum 31: 462–466PubMedCrossRefGoogle Scholar
  631. 30.
    Ueki H, Kohda M (1979) Multilokulärer extramammärer Morbus Paget. Hautarzt 30: 267–270PubMedGoogle Scholar
  632. 31.
    Webb AT (1965) Occult Paget's disease of the anus. Report of a case. Dis Colon Rectum 8: 286CrossRefGoogle Scholar
  633. 32.
    Whorton CM, Patterson JB (1955) Carcinoma of Moll's glands with extramammary Paget's disease of the eyelid. Cancer 8: 1009PubMedCrossRefGoogle Scholar
  634. 1.
    Bank A, Christensen C (1988) Unusual manifestation of Langerhans' ceU histiocytosis. Acta Med Scand 223/5: 479–480Google Scholar
  635. 2.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York TokyoCrossRefGoogle Scholar
  636. 3.
    Burgdorf WHC (1986) Malignant histiocytic infiltrates. In: Murphy GF, Mihm MC Jr (eds) Lymphoproliferative disorders of the skin. Butterworths, Boston, pp 217–255Google Scholar
  637. 4.
    Caputo R (1998) Text and atlas of histiocytic syndromes. Martin Dunitz, LondonGoogle Scholar
  638. 5.
    Cavender PA, Bennett RG (1988) Perianal eosinophilic granuloma resembling condyloma latum. Pediatr Dermatol 5/1: 50–55CrossRefGoogle Scholar
  639. 6.
    Favara BE, Feller AC, Pauli M et al. (1997) Contemporary classification of histiocytic dis orders (The WHO Committee on Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society) Med Pedriatr Oncol29/3: 157–166CrossRefGoogle Scholar
  640. 7.
    Gadner H (1999) Langerhans cell histiocytosis-still an unsolved problem? Pediatr Hematol Oncol 16/6: 489–493CrossRefGoogle Scholar
  641. 8.
    Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S (1994) Treatment strategy for disseminated Langerhans ceU histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol 23/2: 72–80CrossRefGoogle Scholar
  642. 9.
    Gianotti F, Caputo R (1985) Histiozytic syndromes: A review. J Am Acad Dermatol 13: 383–404PubMedCrossRefGoogle Scholar
  643. 10.
    Grundy P, Ellis R (1986) Histiocytosis X: a review of the etiology, pathology, staging and therapy. Med Pediatr Oncol 14: 45–50PubMedCrossRefGoogle Scholar
  644. 11.
    Hoting E et al. (1988) Histiozytosis X.Aktuel Dermatol 14: 139–141Google Scholar
  645. 12.
    Kader HA, RucheHi E, Maller ES (1998) Langerhans' cell histiocytosis with stool retention caused by a perianal mass. J Pedriatr Gastroenterol Nutr 26/2: 226–228CrossRefGoogle Scholar
  646. 13.
    Lichtenstein (1953) Histiocytosis X: integration of eosinophilic granuloma of bones, Letterer-Siwe disease and Schuller-Christian disease as related manifestations of a single nosologic entity. Arch Pathol Lab Med 56: 84–102Google Scholar
  647. 14.
    Mejia R, Dano JA, Roberts R, Wiley E, Cockerell CJ, Cruz PD Jr (1997) Langerhans' cell histiocytosis in adults. J Am Acad Dermatol 37: 314–317PubMedCrossRefGoogle Scholar
  648. 15.
    Nezelof C, Frileux-Herbert F, Cronier-Sachot J (1979) Disseminated histiocytosis X: analysis of prognostic factors based on a retrospective study of 50 cases. Cancer 44: 1824–1838PubMedCrossRefGoogle Scholar
  649. 16.
    Snow JL, Su WP (1995) Histiocytic diseases. J Am Dermatol 33/1: 111–116CrossRefGoogle Scholar
  650. 17.
    Torok L, Tiszlavicz L, Somogyi T, Toth G, Tapai M (2000) Perianal ulcer as a leading symptom of paedriatric Langerhans' cell histiocytosis. Acta Derm Venereol 80/1: 49–51Google Scholar
  651. 1.
    Braun-Falco O, Plewig G, Wolff HH (1996) Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 863Google Scholar
  652. 2.
    Elliot GT (1893) Adeno-cystoma intracanaliculare occuring in a naevus unius lateris. J Cut Genitourin Dis 11:168. Zit. nach Helwig EB, Hackney VC (1955)Google Scholar
  653. 3.
    Ishida-Yamamoto A, Sato K, Wada T, Takahashi H, Iizuka H (2001) Syringocystadenocarcinoma papilliferum: Case report and immunohistochemical comparison with its benign counterpart. J Am Acad Dermatol 45/5: 755–759CrossRefGoogle Scholar
  654. 4.
    Ishikowa K (1987) Syringocystadenoma papilliferum, syringadenoma papilliferum. In: Ishikowa K (ed) Adnexal tumors of the skin. Springer, Berlin Heidelberg New York, pp 96–97CrossRefGoogle Scholar
  655. 5.
    Mlitz H (1988) Syringozystadenom der Perianalregion. In: Junghans PC, Brühl W, Zenner O (Hrsg) Aktuelle Koloproktologie, Bd 5. Edition Nymphenburg, München, S 133-136Google Scholar
  656. 6.
    Niebauer G (1983) Naevus syringocystadenomatosus papilliferus Pinkus (hydrocystoma-WHO). In: Luger A, Gschnait F (Hrsg) Dermatologische Onkologie. Urban & Schwarzenberg, Wien München Baltimore, S 88–89Google Scholar
  657. 7.
    Pinkus H (1954) Life history of naevus syringadenomatosus papilliferus. Arch Dermatol 69: 305–322CrossRefGoogle Scholar
  658. 8.
    Pullmann H, Pfeiff B (1985) Syringocystadenoma papilliferum als Differentialdiagnose eines Unterlippencarcinoms. Hautarzt 60/4: 348–355Google Scholar
  659. 9.
    Rupec M, Horn MuW (1981) Benigne Tumoren der Haut. In: Korting GW (Hrsg) Dermatologie in Praxis und Klinik, Bd IV. Thieme, Stuttgart, S 40.61–40.62Google Scholar
  660. 10.
    Skelton HG 3rd, Smith KJ, Young D, Lupton GP (1994) Condylomata acuminatum associated with syringocystadenoma papilliferum. Am J Dermatopathol 16/6: 628–630CrossRefGoogle Scholar
  661. 11.
    Werther J (1913) Syringadenoma papilliferum (Naevus syringadenomatosus papilliferus). Arch Dermatol Syph (Berl) 116: 865–870Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Ernst Stein
    • 1
  1. 1.Arzt für Dermatologie — AllergologieLimburgerhofGermany

Personalised recommendations